data_2lhu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lhu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -56.02 -42.57 76.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.206 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.72 -45.08 79.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.189 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 92.9 mt -69.7 -40.11 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.6 -31.24 56.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.192 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -54.27 -42.69 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -110.42 -9.93 14.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 -173.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -80.77 151.4 70.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.08 155.33 61.65 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.692 1.595 . . . . 0.0 111.219 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.97 -20.15 45.14 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.723 1.615 . . . . 0.0 111.201 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.4 p -76.13 -19.92 58.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.244 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -109.23 8.8 25.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.205 -175.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -64.64 -33.85 76.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.173 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.88 -36.92 64.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.196 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -67.87 -34.27 76.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.195 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 42.2 mm -76.68 -47.8 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.176 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.61 72.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -65.81 -29.87 70.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.194 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -63.57 -31.19 72.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -100.4 1.91 41.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.218 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.59 56.72 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.52 117.41 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.221 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 80.7 p -99.98 -27.89 13.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -85.22 73.27 10.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.189 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.4 -38.93 88.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.75 -45.0 93.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.79 -38.42 95.56 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 62.9 tpp -64.21 -35.79 81.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 111.212 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.89 -26.36 49.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.02 -35.11 77.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.242 169.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.92 -27.78 57.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.8 tp -65.03 -51.2 62.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.164 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 -178.622 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' A' ' 321' ' ' LEU . 10.0 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.739 0.305 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -81.09 -22.91 38.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.173 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.17 -30.44 67.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.187 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.0 mm -81.49 -41.31 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.273 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 317' ' ' VAL . 81.6 mt -60.1 -35.03 74.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.24 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 54.4 tpt85 -65.27 -30.03 70.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -104.99 -36.01 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -169.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -81.07 158.05 70.4 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.221 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.05 153.73 56.01 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.717 1.611 . . . . 0.0 111.181 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.62 -17.01 38.45 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.696 1.597 . . . . 0.0 111.221 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.5 p -75.4 -14.91 60.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -100.09 -4.01 30.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -60.03 -31.62 70.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 -170.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.2 -50.53 71.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.01 -28.84 55.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.228 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.54 -44.4 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.62 84.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.212 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -62.0 -30.83 71.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.189 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -64.91 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -103.2 5.26 37.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 76.97 21.25 74.5 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 89.8 t -86.19 125.84 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 111.197 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.1 p -100.47 -27.48 13.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -95.37 82.32 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.216 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 49.2 tp -59.69 -49.57 77.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.26 -34.42 73.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.188 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.12 95.63 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.8 mmt -75.95 -25.74 56.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 111.221 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 92.0 mt -74.6 -21.67 59.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.191 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.03 -23.8 48.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.202 169.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -74.6 -14.86 60.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.55 -27.03 64.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.213 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -179.473 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.807 0.337 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -81.4 -24.09 37.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.194 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -71.74 -40.14 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.3 mm -82.9 -48.59 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 79.7 mt -55.19 -33.51 63.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.14 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -54.79 -43.9 73.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.193 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -111.79 -7.48 14.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -170.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -76.19 156.56 83.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.01 149.02 91.98 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.708 1.605 . . . . 0.0 111.192 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.03 -20.05 38.81 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.668 1.578 . . . . 0.0 111.258 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.5 p -77.57 -15.33 59.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.226 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -100.08 -7.19 25.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 -173.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -61.26 -36.3 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 -169.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.97 -49.81 74.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -70.44 -34.85 72.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.223 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 87.9 mt -67.74 -51.69 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.45 79.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.216 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -66.73 -30.05 70.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.194 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -62.9 -30.17 71.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.213 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -96.5 2.84 52.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.39 24.84 69.67 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 91.0 t -102.55 123.29 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 111.215 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.0 p -100.74 -23.95 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.8 71.14 10.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.4 -40.07 77.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.34 -44.96 96.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.131 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -67.85 -39.21 89.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 54.0 tpp -65.04 -43.32 92.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.186 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.96 -33.28 65.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.219 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.0 -40.2 95.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.163 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.53 -35.29 79.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.214 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.09 -38.97 79.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.226 175.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--O 1.2 -1.537 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.255 179.081 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 70.9 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.749 0.309 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -73.53 -20.71 60.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.82 -34.52 62.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.95 -40.11 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.223 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 1.3 mp -67.63 -22.02 65.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.268 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -46.04 -50.05 15.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.189 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -105.37 6.0 32.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.198 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -83.77 146.41 49.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 32.7 Cg_exo -57.89 147.7 80.06 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.659 1.572 . . . . 0.0 111.196 172.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 78.2 Cg_exo -53.93 -34.77 77.84 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.666 1.577 . . . . 0.0 111.212 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 87.5 p -72.96 -20.06 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.252 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -99.85 0.37 41.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.216 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -56.19 -52.81 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.21 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.62 -40.28 66.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.257 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.84 -35.49 81.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.171 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 97.1 mt -78.66 -46.89 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.41 -39.07 72.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.188 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -63.61 -30.32 71.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -74.18 -16.47 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -100.22 -4.12 30.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.248 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 84.51 22.55 53.57 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 88.3 t -108.17 120.46 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 0.0 111.152 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.1 p -106.09 -16.72 14.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.189 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -85.12 76.66 10.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.195 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.95 -37.5 87.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.232 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.71 -39.71 85.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.58 -41.14 99.84 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -66.5 -36.36 82.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 111.195 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.86 -26.89 57.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.66 -35.43 70.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 172.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.77 -30.38 61.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.196 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 54.2 tp -72.64 -50.32 25.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.248 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.2 -1.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 -178.385 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.864 0.364 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -59.04 -30.05 67.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.223 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.48 -46.45 69.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.55 -32.37 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 321' ' ' LEU . 0.3 OUTLIER -58.99 -25.6 63.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -176.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -56.35 -44.81 80.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.214 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -105.92 -12.28 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -172.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -82.56 150.83 63.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.179 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.87 152.57 47.0 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.691 1.594 . . . . 0.0 111.233 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.86 -33.46 81.77 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.689 1.593 . . . . 0.0 111.206 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 95.2 p -71.96 -21.06 61.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.187 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -108.72 7.39 26.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.176 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -59.15 -45.09 91.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.246 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.83 -40.24 94.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.21 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -64.97 -38.87 92.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.17 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.9 mm -65.02 -44.4 95.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.265 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.36 81.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.232 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -62.35 -34.76 77.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.179 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.89 -25.16 63.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -103.83 -1.71 27.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.194 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.16 25.32 69.05 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.84 125.88 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.331 . . . . 0.0 111.179 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.6 p -102.78 -24.91 13.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.166 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -86.3 72.15 10.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.281 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.41 -34.88 79.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.38 -45.39 88.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.178 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -63.3 -35.78 92.52 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 36.7 mmt -65.05 -41.96 94.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 111.216 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.19 -31.5 67.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.27 -32.86 70.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.22 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -75.1 -34.85 61.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.62 -52.0 43.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.184 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.199 -1.554 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.139 -177.022 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.867 0.365 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -74.95 -20.83 59.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.272 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.37 -30.27 64.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.243 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 95.3 mt -72.45 -40.11 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.237 170.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.416 HD23 ' CD1' ' A' ' 329' ' ' TYR . 96.2 mt -61.79 -25.64 67.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.208 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -55.04 -40.47 70.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.253 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -100.09 -30.03 12.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 -173.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -65.1 145.04 99.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.208 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 39.5 Cg_exo -59.3 151.79 65.21 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.722 1.614 . . . . 0.0 111.249 172.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.75 -24.48 61.88 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.716 1.611 . . . . 0.0 111.162 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 93.7 p -78.44 -18.48 54.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -100.03 0.48 41.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.276 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . 0.416 ' CD1' HD23 ' A' ' 321' ' ' LEU . 9.6 m-30 -60.01 -34.19 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.181 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.05 -42.93 88.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.58 -34.68 72.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.25 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 37.2 mm -64.39 -43.4 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.189 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.21 99.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.182 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -65.29 -30.03 70.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -65.08 -33.57 76.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.207 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -105.39 -8.55 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.88 25.21 53.55 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.6 t -81.68 125.03 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.749 0.309 . . . . 0.0 111.178 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.0 p -96.01 -24.66 16.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.189 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -97.84 70.69 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.23 -40.22 95.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.175 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.57 -36.68 85.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.27 -41.16 99.74 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 24.8 mmt -65.14 -34.98 79.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 0.0 111.221 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.08 -25.32 58.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.45 -34.48 65.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.221 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.27 -34.29 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.0 -47.69 67.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 175.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.54 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 179.051 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 76.0 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.828 0.347 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -66.15 -27.26 67.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.228 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.25 -40.06 89.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.233 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.45 -41.06 85.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.234 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.04 -30.49 71.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -52.27 -41.28 62.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.185 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -109.45 20.73 17.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -109.57 159.4 31.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.162 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 42.7 Cg_exo -58.95 131.72 43.36 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.663 1.575 . . . . 0.0 111.237 177.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 75.3 Cg_exo -54.69 -34.89 85.68 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.686 1.591 . . . . 0.0 111.182 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.4 p -72.86 -15.7 61.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.196 -174.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -104.75 5.48 33.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.207 -174.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -63.72 -38.2 90.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.204 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.31 -49.73 74.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.174 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.36 -39.25 81.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.258 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 93.5 mt -69.98 -50.06 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.51 -45.03 92.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.204 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -66.35 -32.9 74.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -63.52 -30.19 71.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.159 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -83.68 -11.8 56.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.205 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 96.97 18.59 28.99 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.54 122.76 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 111.239 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 70.2 p -95.02 -20.04 19.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.216 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -106.12 81.74 1.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.208 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.41 -50.71 72.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.64 -39.02 92.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.226 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.11 -38.57 96.16 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 59.8 tpp -70.14 -30.88 68.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.96 -22.51 49.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.173 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.22 -32.97 67.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.35 -31.55 70.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.47 ' C ' HD21 ' A' ' 348' ' ' LEU . 4.4 tt -62.98 -57.18 11.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.203 175.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.521 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.221 -179.124 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.803 0.335 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -79.61 -43.25 23.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.207 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.02 -32.08 70.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 41.9 mm -74.63 -44.02 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.226 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 321' ' ' LEU . 0.4 OUTLIER -58.95 -28.38 66.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 -178.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -63.67 -29.77 70.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.142 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -113.19 -13.64 12.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.251 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -90.48 150.68 43.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.27 155.99 63.01 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.719 1.613 . . . . 0.0 111.19 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -70.68 -16.41 33.68 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.698 1.598 . . . . 0.0 111.243 -172.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 85.5 p -71.96 -21.85 61.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.242 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -105.49 0.32 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.166 -170.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -59.35 -34.63 72.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.08 -50.03 69.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.238 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.28 -35.22 71.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.175 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.69 -44.8 99.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.212 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -57.27 -43.07 82.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -62.68 -34.76 77.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.194 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -67.56 -24.88 65.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.239 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -100.03 3.45 44.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.226 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.76 24.75 73.67 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.6 t -97.69 119.24 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 111.232 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.0 p -98.89 -29.96 12.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.209 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -111.09 86.4 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.219 172.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 49.2 tp -66.67 -39.24 88.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.251 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.04 -47.85 84.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -68.39 -35.93 83.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 16.7 tpt -64.33 -41.26 96.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 111.266 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 98.4 mt -72.31 -33.77 67.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.207 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.8 -34.08 77.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.196 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -69.91 -42.15 73.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.228 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 98.6 mt -74.9 -32.38 61.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.166 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.199 -1.561 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.192 -179.276 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.731 0.301 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -55.17 -27.96 49.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.226 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.22 -36.37 83.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.235 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.0 mt -76.6 -40.88 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.205 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.66 -35.04 75.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.219 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -56.33 -38.6 71.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.222 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -104.74 19.37 20.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -116.81 149.34 43.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 31.3 Cg_exo -59.85 146.69 95.09 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.705 1.603 . . . . 0.0 111.215 175.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 65.6 Cg_exo -54.94 -33.29 81.93 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.794 1.663 . . . . 0.0 111.153 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 92.9 p -71.22 -16.19 62.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 -174.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -100.04 -2.27 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -60.05 -44.97 94.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.248 -176.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.6 -36.76 70.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.255 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.63 -37.0 68.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.18 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 85.1 mt -66.1 -49.97 72.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.191 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.37 74.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.118 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -55.01 -45.78 75.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.217 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -60.8 -35.15 75.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -100.01 4.22 44.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.263 -173.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 74.69 25.15 70.55 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.6 122.02 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.377 . . . . 0.0 111.193 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 80.6 p -97.58 -23.59 15.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.218 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -97.86 71.88 2.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.5 -41.27 96.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -62.4 -39.3 92.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.38 -36.11 92.79 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -70.85 -31.79 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.145 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.6 mt -76.14 -25.18 55.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.24 -35.0 73.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.34 -31.15 60.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.646 ' C ' HD21 ' A' ' 348' ' ' LEU . 4.3 tt -55.88 -56.56 19.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.237 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.55 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.231 -178.77 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.811 0.339 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -58.61 -25.56 62.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.193 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.22 -34.84 79.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.189 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.48 -41.91 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.181 173.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.42 -33.4 74.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -53.87 -41.54 67.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.186 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -100.75 5.22 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.219 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -96.16 150.92 37.81 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 -176.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 38.1 Cg_exo -60.24 151.84 70.69 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.709 1.606 . . . . 0.0 111.21 173.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.49 -24.19 49.49 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.681 1.587 . . . . 0.0 111.197 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.8 p -78.41 -18.48 54.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -100.39 0.12 39.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.256 -173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -57.58 -51.72 68.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.259 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.14 -43.83 77.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.204 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.04 -37.22 86.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.2 -174.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.0 -50.0 45.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.46 -42.57 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.3 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -65.66 -31.52 72.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.223 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.88 -18.93 62.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -102.02 5.93 40.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.216 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.06 23.75 73.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 89.8 t -99.64 116.05 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.836 0.35 . . . . 0.0 111.204 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.6 p -97.39 -28.35 14.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.248 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -85.05 75.47 10.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.159 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 65.5 tp -62.59 -46.14 89.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.26 -39.22 89.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -56.99 -38.78 87.39 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.4 mmt -74.99 -37.2 61.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.146 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.98 -28.2 69.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.236 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.01 -24.52 60.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -83.98 -33.51 24.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.208 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 348' ' ' LEU . 2.2 pp -78.62 -23.26 45.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.199 -1.576 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.172 179.285 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 75.4 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.823 0.344 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -63.53 -21.43 66.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.18 -173.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.04 -25.82 62.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 49.6 mm -90.01 -32.32 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.428 HD23 ' CD1' ' A' ' 329' ' ' TYR . 90.1 mt -59.32 -27.62 66.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.266 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -54.84 -43.24 72.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.14 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -107.68 -9.93 15.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 -173.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -77.58 148.25 76.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.226 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 31.5 Cg_exo -58.02 143.75 95.77 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.725 1.617 . . . . 0.0 111.169 173.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.39 -21.11 41.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.699 1.599 . . . . 0.0 111.164 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 86.9 p -81.8 -20.5 39.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -100.64 -0.65 37.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.218 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . 0.428 ' CD1' HD23 ' A' ' 321' ' ' LEU . 6.2 m-30 -50.03 -51.45 42.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 -175.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.03 -42.97 63.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.179 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.07 -37.33 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.279 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 38.3 mm -58.8 -40.72 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.29 96.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -63.5 -29.96 71.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.292 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -62.0 -27.48 68.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.198 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -103.07 3.36 35.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.227 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 77.32 24.69 65.22 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 90.7 t -104.19 129.13 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 111.176 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.3 p -103.26 -20.12 14.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -84.9 75.42 10.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 64.0 tp -64.9 -40.52 95.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.163 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.33 -37.22 86.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.225 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -63.24 -37.76 95.39 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 39.0 mmt -71.93 -30.9 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.729 0.299 . . . . 0.0 111.195 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.66 -28.79 61.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.208 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.25 -35.76 74.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.226 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.21 -28.41 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.179 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 68.4 tp -65.08 -52.89 52.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.152 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.524 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 -178.628 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.704 0.288 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -85.12 -23.88 28.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.177 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.59 -36.71 76.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.63 -40.86 33.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.265 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.3 OUTLIER -56.11 -29.48 60.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.302 178.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -54.62 -42.2 70.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.201 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -110.76 -10.88 14.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -77.07 145.2 73.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.216 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 36.9 Cg_exo -59.82 149.92 80.55 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.704 1.602 . . . . 0.0 111.174 173.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -54.8 -34.32 84.5 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.681 1.588 . . . . 0.0 111.2 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 94.8 p -74.4 -17.03 60.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.177 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -99.93 -0.97 38.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.267 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -60.39 -41.42 93.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.219 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.26 -32.44 71.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -71.25 -35.62 71.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.212 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 46.7 mm -75.1 -45.0 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.22 -38.33 79.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -55.64 -49.07 73.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.196 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.99 -35.09 79.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.254 -176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -79.92 -22.31 42.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.235 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 86.89 26.36 32.0 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 94.6 t -87.04 124.89 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.769 0.319 . . . . 0.0 111.254 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.4 p -97.17 -25.73 15.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.195 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -99.08 78.19 2.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.184 175.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.3 tp -62.21 -44.91 95.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.264 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.13 -37.19 86.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 -176.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -59.74 -40.74 97.0 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.8 mmt -72.38 -33.84 67.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.351 . . . . 0.0 111.214 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.11 -29.73 66.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.199 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.34 -34.94 48.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -87.15 -6.06 58.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.505 ' C ' HD21 ' A' ' 348' ' ' LEU . 5.8 tt -51.76 -57.57 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.2 176.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.499 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 179.925 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 79.1 t . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.836 0.351 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -75.86 -22.37 56.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.23 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.25 -33.19 69.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 170.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.6 mt -70.24 -44.19 77.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.234 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 96.8 mt -60.62 -30.79 70.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.188 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -51.74 -40.47 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.209 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -108.3 -10.04 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -74.79 152.67 87.02 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.249 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 41.5 Cg_exo -57.84 132.27 48.83 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.753 1.635 . . . . 0.0 111.185 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 75.4 Cg_exo -54.6 -35.22 85.81 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.69 1.593 . . . . 0.0 111.208 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.1 p -75.12 -17.24 60.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -106.93 17.04 23.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.182 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -64.91 -32.6 74.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.218 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.92 -43.55 68.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.51 -40.51 93.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.88 -44.96 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.229 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.07 -57.14 12.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -70.31 -24.1 62.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.163 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -61.76 -30.18 70.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.179 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -104.83 9.92 34.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.279 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.4 18.88 67.73 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 85.8 t -96.1 125.08 49.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 111.173 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 58.6 p -102.01 -24.84 13.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.218 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -93.53 84.08 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.198 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 50.6 tp -64.93 -46.07 83.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.206 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.73 -34.77 76.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.167 -176.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -60.27 -38.25 94.28 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.7 mmt -74.47 -32.64 62.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.192 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 94.4 mt -73.01 -24.95 60.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.205 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.99 -35.0 74.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.31 -32.16 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.223 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.469 ' O ' HD21 ' A' ' 348' ' ' LEU . 4.3 tt -57.39 -55.49 34.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.489 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -178.988 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 75.0 t . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.781 0.325 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 -75.61 -19.53 59.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.157 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.24 -36.9 77.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.227 172.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.11 -42.68 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 171.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.45 -35.13 75.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.253 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -56.22 -40.2 73.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.261 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -98.1 4.39 49.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -100.65 156.73 34.85 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.69 152.52 64.54 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.7 1.6 . . . . 0.0 111.203 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -70.34 -18.09 34.5 Favored 'Trans proline' 0 C--N 1.327 -0.566 0 C-N-CA 121.67 1.58 . . . . 0.0 111.172 -172.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.9 p -77.63 -16.87 58.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.191 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -112.47 9.79 19.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.195 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -66.49 -35.69 80.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.277 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -72.16 -39.11 68.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.224 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.16 -39.05 89.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.171 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 93.0 mt -70.01 -49.92 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.11 -48.71 75.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.169 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -66.81 -28.7 68.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.218 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -65.04 -30.03 70.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -93.45 -9.37 38.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 88.7 17.94 55.66 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 88.0 t -93.75 124.83 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 111.183 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.4 p -100.43 -26.59 13.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.243 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -85.18 75.0 10.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.199 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.2 -43.37 95.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.63 -37.09 80.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -61.89 -38.76 96.54 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -72.11 -30.69 65.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 111.243 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.05 -26.13 59.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.154 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.81 -35.06 77.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.137 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.13 -32.37 50.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 173.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.676 ' C ' HD21 ' A' ' 348' ' ' LEU . 4.2 tt -54.95 -53.05 60.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 175.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.201 -1.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.203 -179.408 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.826 0.346 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -65.28 -20.07 66.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.12 -33.48 73.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.238 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.2 mt -72.14 -39.53 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.261 170.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 329' ' ' TYR . 92.5 mt -67.4 -20.95 65.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.191 -178.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -52.37 -44.27 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.243 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -108.39 15.54 23.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.196 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -100.51 147.75 34.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.151 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 37.2 Cg_exo -60.77 145.6 98.7 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.705 1.604 . . . . 0.0 111.233 173.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 76.7 Cg_exo -53.95 -34.11 75.28 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.686 1.591 . . . . 0.0 111.216 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 92.0 p -71.64 -19.48 62.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.219 -175.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -100.02 -0.56 38.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.202 -174.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . 0.4 ' HA ' HD23 ' A' ' 321' ' ' LEU . 11.9 m-30 -58.77 -50.78 72.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 -178.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.99 -42.62 89.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.176 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.39 -38.03 84.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 86.9 mt -68.4 -46.47 80.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.202 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -54.86 -45.63 74.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.186 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -65.31 -30.04 70.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -70.3 -21.87 62.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -104.79 8.58 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.279 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.01 24.83 70.67 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 93.9 t -102.01 121.2 52.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.761 0.315 . . . . 0.0 111.241 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.5 p -102.9 -26.51 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.206 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -85.03 74.8 10.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.26 177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.73 -40.0 91.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.282 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.91 -35.76 82.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.217 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -65.14 -36.95 93.54 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -72.69 -38.09 67.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 111.151 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.86 -20.25 59.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.27 -42.3 65.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.21 -33.78 76.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.201 174.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.05 -48.49 68.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.505 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 178.86 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.789 0.328 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -73.89 -21.59 60.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.211 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -72.11 -37.16 69.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 171.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.9 mt -65.05 -42.55 94.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 170.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.03 -34.19 77.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.236 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -57.27 -40.98 78.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -98.88 20.83 12.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.19 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -119.7 156.93 53.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.249 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.57 149.55 61.87 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.65 1.567 . . . . 0.0 111.14 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.47 -15.39 27.8 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.663 1.575 . . . . 0.0 111.266 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.0 p -78.69 -15.29 58.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.215 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.75 25.01 8.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.221 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -72.36 -36.15 68.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.198 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.57 -39.5 73.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.162 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.04 -38.0 89.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 91.3 mt -69.54 -51.78 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.199 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.47 -42.94 75.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -65.86 -29.88 70.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.252 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -75.57 -13.43 60.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.252 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -105.01 1.41 28.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.197 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.83 24.94 68.31 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 92.3 t -100.14 116.72 44.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.778 0.323 . . . . 0.0 111.154 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.8 p -95.9 -27.56 15.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.208 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -84.96 74.82 10.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.22 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 55.0 tp -64.27 -42.28 96.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.165 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.89 -36.32 80.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.253 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -60.54 -39.91 97.08 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.3 mmt -71.54 -32.42 68.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.204 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.09 -24.9 58.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.02 -35.01 74.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 172.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.08 -33.39 61.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.205 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.523 ' C ' HD21 ' A' ' 348' ' ' LEU . 4.7 tt -56.92 -55.15 38.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.5 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 -178.902 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.409 ' O ' ' HG ' ' A' ' 321' ' ' LEU . 2.5 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -78.54 -18.28 54.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.273 -174.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.97 -35.25 62.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.262 171.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.4 mt -76.79 -36.55 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.191 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 317' ' ' VAL . 62.4 mt -55.33 -32.64 62.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.173 178.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.22 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -104.98 1.13 28.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.192 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -97.57 143.43 26.17 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.12 -176.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 31.8 Cg_exo -59.3 151.68 65.99 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.729 1.62 . . . . 0.0 111.203 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 75.7 Cg_exo -55.09 -35.16 89.82 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.757 1.638 . . . . 0.0 111.161 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.4 p -74.35 -18.23 60.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.244 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -100.05 1.12 42.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.248 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -53.54 -51.54 62.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.7 -42.03 99.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.247 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.05 -38.71 89.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 -175.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 33.6 mm -63.75 -41.96 94.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.261 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.35 90.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.193 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -64.22 -32.78 74.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -65.1 -26.74 68.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -102.64 -1.18 30.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.168 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.01 24.98 70.24 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 84.4 t -96.25 125.16 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 111.17 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.4 p -96.73 -25.46 15.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -84.96 74.86 10.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 63.8 tp -64.09 -44.29 92.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.2 -38.92 88.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 -176.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.74 -36.96 94.05 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.9 mmt -74.92 -28.94 60.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.83 0.348 . . . . 0.0 111.239 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.3 mt -74.89 -24.05 58.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -69.97 -30.33 67.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.244 171.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.59 -31.79 41.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.655 ' C ' HD21 ' A' ' 348' ' ' LEU . 3.9 tt -53.85 -59.24 4.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.165 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.201 -1.495 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.295 -178.269 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.798 0.333 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -62.47 -22.71 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.54 -34.46 77.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.193 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.96 -41.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.192 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 3.8 mp -63.39 -26.92 68.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -54.18 -40.26 67.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.248 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -110.74 19.66 18.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.186 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -110.97 149.65 40.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 32.2 Cg_exo -57.99 154.56 38.26 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.765 1.643 . . . . 0.0 111.175 174.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.24 -21.7 47.68 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.743 1.629 . . . . 0.0 111.205 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.3 p -77.36 -16.31 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.259 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -99.85 -3.04 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.191 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -59.28 -50.47 73.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.216 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.82 -48.62 68.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.188 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -60.3 -54.35 46.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.23 -176.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 97.4 mt -56.98 -45.98 83.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.168 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.59 -45.31 77.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -65.32 -30.74 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.193 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -69.14 -22.32 63.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.245 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -104.79 5.54 33.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 77.89 24.12 65.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.2 t -98.88 122.71 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.8 p -104.5 -25.0 12.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.235 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -84.9 73.84 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.28 -39.41 89.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.168 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.54 -36.09 83.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.175 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.87 -41.1 97.62 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 36.8 mmt -66.78 -40.46 88.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 111.181 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.8 -26.27 59.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.75 -43.25 84.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 172.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -77.49 -20.73 53.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.525 ' C ' HD21 ' A' ' 348' ' ' LEU . 5.6 tt -64.94 -56.19 14.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 173.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.201 -1.484 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.183 -178.266 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 74.9 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.815 0.341 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -55.03 -28.91 55.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.58 -35.13 78.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.219 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.12 -36.32 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.199 172.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 329' ' ' TYR . 68.7 mt -69.96 -20.1 63.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -52.16 -40.94 62.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -110.2 20.13 18.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.246 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -114.24 146.37 35.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.66 153.26 43.66 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.712 1.608 . . . . 0.0 111.172 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.16 -21.05 49.16 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.66 1.574 . . . . 0.0 111.201 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 95.4 p -76.97 -15.72 59.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -99.98 -1.84 36.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.223 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . 0.4 ' HA ' HD23 ' A' ' 321' ' ' LEU . 12.0 m-30 -60.37 -49.61 76.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.03 -48.02 75.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.235 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -60.81 -52.53 64.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 91.0 mt -57.16 -49.01 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.71 -46.83 77.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.191 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -63.01 -34.75 78.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.248 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.4 -24.61 66.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -98.63 3.01 47.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.145 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.17 22.03 61.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 97.9 t -104.95 113.18 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 111.184 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 78.0 p -95.74 -20.01 19.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -84.89 74.77 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.171 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.15 -39.82 90.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.159 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.37 -34.95 74.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.157 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -61.37 -43.62 99.12 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.3 mmt -67.45 -30.88 70.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 111.197 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.06 -31.84 61.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.231 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.9 -33.25 71.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.188 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -79.78 -28.0 40.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.178 174.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.4 tp -66.32 -48.62 69.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.224 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.199 -1.559 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.653 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.837 0.351 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -84.44 -22.2 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.248 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.27 -41.91 84.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.258 174.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.49 -40.07 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.4 OUTLIER -53.71 -29.96 41.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.202 178.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -53.97 -45.27 71.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.196 176.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -102.5 -15.48 16.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.177 -173.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -82.07 152.09 67.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.232 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.422 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 87.5 Cg_endo -73.4 147.29 41.23 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.696 1.597 . . . . 0.0 111.175 175.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 76.9 Cg_exo -54.48 -31.28 68.22 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.735 1.623 . . . . 0.0 111.203 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.0 p -68.38 -19.86 64.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.208 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -116.92 23.57 11.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.174 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -70.16 -29.93 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.208 174.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -72.25 -35.16 68.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -71.89 -34.34 69.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.228 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.35 -45.47 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.01 77.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -53.85 -44.54 70.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -68.96 -27.59 65.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -95.19 -7.9 37.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.218 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 78.63 26.12 59.48 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.86 129.07 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 111.197 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 71.3 p -115.18 5.08 14.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.182 -176.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -130.33 91.93 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.204 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 83.2 mt -74.72 -23.76 58.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.23 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.16 -37.05 75.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.182 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -66.89 -35.31 89.37 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.7 mmt -74.67 -29.91 61.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.824 0.345 . . . . 0.0 111.219 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.88 -35.69 80.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.23 -34.04 74.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -75.07 -29.77 60.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.245 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 98.1 mt -74.36 -29.75 61.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.199 -1.56 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.18 179.331 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -79.9 169.98 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.206 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 69.9 t -65.3 -49.67 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.23 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -56.02 -42.57 76.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.206 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.72 -45.08 79.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.189 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 92.9 mt -69.7 -40.11 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.6 -31.24 56.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.192 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -54.27 -42.69 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -110.42 -9.93 14.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 -173.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -80.77 151.4 70.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.08 155.33 61.65 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.692 1.595 . . . . 0.0 111.219 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.97 -20.15 45.14 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.723 1.615 . . . . 0.0 111.201 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.4 p -76.13 -19.92 58.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.244 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -109.23 8.8 25.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.205 -175.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -64.64 -33.85 76.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.173 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.88 -36.92 64.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.196 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -67.87 -34.27 76.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.195 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 42.2 mm -76.68 -47.8 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.176 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.61 72.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -65.81 -29.87 70.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.194 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -63.57 -31.19 72.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -100.4 1.91 41.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.218 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.59 56.72 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.52 117.41 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.221 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 80.7 p -99.98 -27.89 13.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -85.22 73.27 10.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.189 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.4 -38.93 88.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.75 -45.0 93.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.79 -38.42 95.56 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 62.9 tpp -64.21 -35.79 81.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 111.212 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.89 -26.36 49.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.02 -35.11 77.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.242 169.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.92 -27.78 57.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.8 tp -65.03 -51.2 62.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.164 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 -178.622 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.78 0.324 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -75.53 158.88 31.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' A' ' 321' ' ' LEU . 10.0 p -62.63 -35.35 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.18 -176.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -81.09 -22.91 38.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.173 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.17 -30.44 67.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.187 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.0 mm -81.49 -41.31 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.273 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 317' ' ' VAL . 81.6 mt -60.1 -35.03 74.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.24 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 54.4 tpt85 -65.27 -30.03 70.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -104.99 -36.01 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -169.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -81.07 158.05 70.4 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.221 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.05 153.73 56.01 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.717 1.611 . . . . 0.0 111.181 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.62 -17.01 38.45 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.696 1.597 . . . . 0.0 111.221 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.5 p -75.4 -14.91 60.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -100.09 -4.01 30.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -60.03 -31.62 70.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 -170.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.2 -50.53 71.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.01 -28.84 55.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.228 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.54 -44.4 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.62 84.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.212 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -62.0 -30.83 71.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.189 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -64.91 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -103.2 5.26 37.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 76.97 21.25 74.5 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 89.8 t -86.19 125.84 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 111.197 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.1 p -100.47 -27.48 13.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -95.37 82.32 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.216 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 49.2 tp -59.69 -49.57 77.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.26 -34.42 73.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.188 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.12 95.63 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.8 mmt -75.95 -25.74 56.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 111.221 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 92.0 mt -74.6 -21.67 59.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.191 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.03 -23.8 48.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.202 169.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -74.6 -14.86 60.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.55 -27.03 64.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.213 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -179.473 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -75.71 159.99 30.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.211 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.46 -34.54 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -81.4 -24.09 37.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.194 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -71.74 -40.14 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.3 mm -82.9 -48.59 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 79.7 mt -55.19 -33.51 63.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.14 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -54.79 -43.9 73.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.193 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -111.79 -7.48 14.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -170.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -76.19 156.56 83.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.01 149.02 91.98 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.708 1.605 . . . . 0.0 111.192 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.03 -20.05 38.81 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.668 1.578 . . . . 0.0 111.258 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.5 p -77.57 -15.33 59.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.226 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -100.08 -7.19 25.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 -173.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -61.26 -36.3 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 -169.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.97 -49.81 74.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -70.44 -34.85 72.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.223 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 87.9 mt -67.74 -51.69 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.45 79.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.216 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -66.73 -30.05 70.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.194 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -62.9 -30.17 71.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.213 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -96.5 2.84 52.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.39 24.84 69.67 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 91.0 t -102.55 123.29 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 111.215 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.0 p -100.74 -23.95 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.8 71.14 10.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.4 -40.07 77.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.34 -44.96 96.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.131 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -67.85 -39.21 89.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 54.0 tpp -65.04 -43.32 92.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.186 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.96 -33.28 65.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.219 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.0 -40.2 95.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.163 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.53 -35.29 79.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.214 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.09 -38.97 79.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.226 175.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--O 1.2 -1.537 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.255 179.081 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 CA--C 1.523 -0.093 0 CA-C-O 120.838 0.352 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -79.83 169.94 17.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.189 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 70.9 t -68.23 -46.13 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.156 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -73.53 -20.71 60.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.82 -34.52 62.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.95 -40.11 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.223 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 1.3 mp -67.63 -22.02 65.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.268 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -46.04 -50.05 15.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.189 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -105.37 6.0 32.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.198 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -83.77 146.41 49.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 32.7 Cg_exo -57.89 147.7 80.06 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.659 1.572 . . . . 0.0 111.196 172.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 78.2 Cg_exo -53.93 -34.77 77.84 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.666 1.577 . . . . 0.0 111.212 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 87.5 p -72.96 -20.06 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.252 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -99.85 0.37 41.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.216 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -56.19 -52.81 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.21 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.62 -40.28 66.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.257 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.84 -35.49 81.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.171 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 97.1 mt -78.66 -46.89 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.41 -39.07 72.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.188 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -63.61 -30.32 71.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -74.18 -16.47 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -100.22 -4.12 30.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.248 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 84.51 22.55 53.57 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 88.3 t -108.17 120.46 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 0.0 111.152 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.1 p -106.09 -16.72 14.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.189 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -85.12 76.66 10.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.195 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.95 -37.5 87.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.232 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.71 -39.71 85.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.58 -41.14 99.84 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -66.5 -36.36 82.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 111.195 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.86 -26.89 57.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.66 -35.43 70.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 172.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.77 -30.38 61.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.196 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 54.2 tp -72.64 -50.32 25.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.248 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.2 -1.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 -178.385 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.783 0.325 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -76.15 162.48 27.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.22 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.33 -53.76 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.209 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -59.04 -30.05 67.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.223 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.48 -46.45 69.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.55 -32.37 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 321' ' ' LEU . 0.3 OUTLIER -58.99 -25.6 63.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -176.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -56.35 -44.81 80.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.214 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -105.92 -12.28 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -172.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -82.56 150.83 63.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.179 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.87 152.57 47.0 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.691 1.594 . . . . 0.0 111.233 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.86 -33.46 81.77 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.689 1.593 . . . . 0.0 111.206 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 95.2 p -71.96 -21.06 61.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.187 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -108.72 7.39 26.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.176 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -59.15 -45.09 91.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.246 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.83 -40.24 94.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.21 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -64.97 -38.87 92.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.17 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.9 mm -65.02 -44.4 95.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.265 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.36 81.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.232 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -62.35 -34.76 77.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.179 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.89 -25.16 63.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -103.83 -1.71 27.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.194 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.16 25.32 69.05 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.84 125.88 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.331 . . . . 0.0 111.179 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.6 p -102.78 -24.91 13.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.166 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -86.3 72.15 10.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.281 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.41 -34.88 79.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.38 -45.39 88.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.178 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -63.3 -35.78 92.52 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 36.7 mmt -65.05 -41.96 94.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 111.216 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.19 -31.5 67.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.27 -32.86 70.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.22 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -75.1 -34.85 61.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.62 -52.0 43.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.184 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.199 -1.554 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.139 -177.022 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.741 0.305 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -77.89 170.02 17.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.162 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.53 -50.42 80.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.259 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -74.95 -20.83 59.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.272 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.37 -30.27 64.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.243 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 95.3 mt -72.45 -40.11 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.237 170.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.416 HD23 ' CD1' ' A' ' 329' ' ' TYR . 96.2 mt -61.79 -25.64 67.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.208 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -55.04 -40.47 70.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.253 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -100.09 -30.03 12.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 -173.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -65.1 145.04 99.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.208 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 39.5 Cg_exo -59.3 151.79 65.21 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.722 1.614 . . . . 0.0 111.249 172.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.75 -24.48 61.88 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.716 1.611 . . . . 0.0 111.162 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 93.7 p -78.44 -18.48 54.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -100.03 0.48 41.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.276 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . 0.416 ' CD1' HD23 ' A' ' 321' ' ' LEU . 9.6 m-30 -60.01 -34.19 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.181 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.05 -42.93 88.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.58 -34.68 72.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.25 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 37.2 mm -64.39 -43.4 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.189 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.21 99.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.182 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -65.29 -30.03 70.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -65.08 -33.57 76.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.207 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -105.39 -8.55 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.88 25.21 53.55 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.6 t -81.68 125.03 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.749 0.309 . . . . 0.0 111.178 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.0 p -96.01 -24.66 16.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.189 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -97.84 70.69 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.23 -40.22 95.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.175 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.57 -36.68 85.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.27 -41.16 99.74 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 24.8 mmt -65.14 -34.98 79.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 0.0 111.221 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.08 -25.32 58.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.45 -34.48 65.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.221 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.27 -34.29 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.0 -47.69 67.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 175.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.54 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 179.051 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.795 0.331 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -75.02 160.55 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.49 -51.13 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -66.15 -27.26 67.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.228 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.25 -40.06 89.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.233 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.45 -41.06 85.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.234 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.04 -30.49 71.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -52.27 -41.28 62.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.185 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -109.45 20.73 17.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -109.57 159.4 31.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.162 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 42.7 Cg_exo -58.95 131.72 43.36 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.663 1.575 . . . . 0.0 111.237 177.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 75.3 Cg_exo -54.69 -34.89 85.68 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.686 1.591 . . . . 0.0 111.182 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.4 p -72.86 -15.7 61.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.196 -174.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -104.75 5.48 33.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.207 -174.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -63.72 -38.2 90.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.204 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.31 -49.73 74.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.174 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.36 -39.25 81.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.258 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 93.5 mt -69.98 -50.06 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.51 -45.03 92.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.204 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -66.35 -32.9 74.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -63.52 -30.19 71.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.159 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -83.68 -11.8 56.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.205 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 96.97 18.59 28.99 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.54 122.76 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 111.239 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 70.2 p -95.02 -20.04 19.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.216 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -106.12 81.74 1.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.208 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.41 -50.71 72.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.64 -39.02 92.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.226 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.11 -38.57 96.16 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 59.8 tpp -70.14 -30.88 68.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.96 -22.51 49.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.173 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.22 -32.97 67.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.35 -31.55 70.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.47 ' C ' HD21 ' A' ' 348' ' ' LEU . 4.4 tt -62.98 -57.18 11.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.203 175.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.521 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.221 -179.124 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.81 0.338 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -82.12 169.91 16.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.5 p -63.53 -30.35 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.176 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -79.61 -43.25 23.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.207 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.02 -32.08 70.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 41.9 mm -74.63 -44.02 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.226 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 321' ' ' LEU . 0.4 OUTLIER -58.95 -28.38 66.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 -178.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -63.67 -29.77 70.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.142 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -113.19 -13.64 12.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.251 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -90.48 150.68 43.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.27 155.99 63.01 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.719 1.613 . . . . 0.0 111.19 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -70.68 -16.41 33.68 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.698 1.598 . . . . 0.0 111.243 -172.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 85.5 p -71.96 -21.85 61.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.242 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -105.49 0.32 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.166 -170.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -59.35 -34.63 72.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.08 -50.03 69.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.238 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.28 -35.22 71.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.175 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.69 -44.8 99.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.212 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -57.27 -43.07 82.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -62.68 -34.76 77.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.194 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -67.56 -24.88 65.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.239 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -100.03 3.45 44.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.226 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.76 24.75 73.67 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.6 t -97.69 119.24 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 111.232 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.0 p -98.89 -29.96 12.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.209 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -111.09 86.4 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.219 172.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 49.2 tp -66.67 -39.24 88.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.251 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.04 -47.85 84.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -68.39 -35.93 83.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 16.7 tpt -64.33 -41.26 96.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 111.266 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 98.4 mt -72.31 -33.77 67.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.207 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.8 -34.08 77.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.196 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -69.91 -42.15 73.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.228 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 98.6 mt -74.9 -32.38 61.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.166 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.199 -1.561 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.192 -179.276 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.824 0.345 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -110.12 44.85 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.196 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.24 -16.79 21.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.198 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -55.17 -27.96 49.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.226 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.22 -36.37 83.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.235 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.0 mt -76.6 -40.88 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.205 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.66 -35.04 75.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.219 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -56.33 -38.6 71.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.222 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -104.74 19.37 20.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -116.81 149.34 43.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 31.3 Cg_exo -59.85 146.69 95.09 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.705 1.603 . . . . 0.0 111.215 175.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 65.6 Cg_exo -54.94 -33.29 81.93 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.794 1.663 . . . . 0.0 111.153 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 92.9 p -71.22 -16.19 62.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 -174.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -100.04 -2.27 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -60.05 -44.97 94.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.248 -176.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.6 -36.76 70.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.255 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.63 -37.0 68.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.18 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 85.1 mt -66.1 -49.97 72.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.191 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.37 74.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.118 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -55.01 -45.78 75.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.217 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -60.8 -35.15 75.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -100.01 4.22 44.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.263 -173.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 74.69 25.15 70.55 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.6 122.02 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.377 . . . . 0.0 111.193 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 80.6 p -97.58 -23.59 15.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.218 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -97.86 71.88 2.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.5 -41.27 96.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -62.4 -39.3 92.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.38 -36.11 92.79 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -70.85 -31.79 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.145 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.6 mt -76.14 -25.18 55.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.24 -35.0 73.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.34 -31.15 60.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.646 ' C ' HD21 ' A' ' 348' ' ' LEU . 4.3 tt -55.88 -56.56 19.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.237 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.55 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.231 -178.77 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.804 0.335 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -109.36 19.65 19.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.215 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.16 -22.88 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.21 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -58.61 -25.56 62.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.193 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.22 -34.84 79.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.189 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.48 -41.91 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.181 173.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.42 -33.4 74.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -53.87 -41.54 67.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.186 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -100.75 5.22 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.219 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -96.16 150.92 37.81 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 -176.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 38.1 Cg_exo -60.24 151.84 70.69 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.709 1.606 . . . . 0.0 111.21 173.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.49 -24.19 49.49 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.681 1.587 . . . . 0.0 111.197 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.8 p -78.41 -18.48 54.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -100.39 0.12 39.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.256 -173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -57.58 -51.72 68.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.259 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.14 -43.83 77.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.204 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.04 -37.22 86.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.2 -174.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.0 -50.0 45.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.46 -42.57 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.3 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -65.66 -31.52 72.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.223 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.88 -18.93 62.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -102.02 5.93 40.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.216 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.06 23.75 73.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 89.8 t -99.64 116.05 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.836 0.35 . . . . 0.0 111.204 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.6 p -97.39 -28.35 14.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.248 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -85.05 75.47 10.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.159 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 65.5 tp -62.59 -46.14 89.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.26 -39.22 89.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -56.99 -38.78 87.39 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.4 mmt -74.99 -37.2 61.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.146 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.98 -28.2 69.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.236 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.01 -24.52 60.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -83.98 -33.51 24.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.208 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 348' ' ' LEU . 2.2 pp -78.62 -23.26 45.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.199 -1.576 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.172 179.285 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -78.87 160.12 27.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.219 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.72 -45.94 80.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.266 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -63.53 -21.43 66.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.18 -173.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.04 -25.82 62.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 49.6 mm -90.01 -32.32 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.428 HD23 ' CD1' ' A' ' 329' ' ' TYR . 90.1 mt -59.32 -27.62 66.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.266 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -54.84 -43.24 72.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.14 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -107.68 -9.93 15.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 -173.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -77.58 148.25 76.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.226 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 31.5 Cg_exo -58.02 143.75 95.77 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.725 1.617 . . . . 0.0 111.169 173.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.39 -21.11 41.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.699 1.599 . . . . 0.0 111.164 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 86.9 p -81.8 -20.5 39.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -100.64 -0.65 37.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.218 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . 0.428 ' CD1' HD23 ' A' ' 321' ' ' LEU . 6.2 m-30 -50.03 -51.45 42.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 -175.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.03 -42.97 63.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.179 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.07 -37.33 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.279 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 38.3 mm -58.8 -40.72 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.29 96.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -63.5 -29.96 71.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.292 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -62.0 -27.48 68.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.198 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -103.07 3.36 35.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.227 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 77.32 24.69 65.22 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 90.7 t -104.19 129.13 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 111.176 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.3 p -103.26 -20.12 14.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -84.9 75.42 10.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 64.0 tp -64.9 -40.52 95.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.163 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.33 -37.22 86.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.225 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -63.24 -37.76 95.39 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 39.0 mmt -71.93 -30.9 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.729 0.299 . . . . 0.0 111.195 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.66 -28.79 61.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.208 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.25 -35.76 74.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.226 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.21 -28.41 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.179 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 68.4 tp -65.08 -52.89 52.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.152 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.524 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 -178.628 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.772 0.32 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.08 157.6 36.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.234 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.15 -35.61 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.213 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -85.12 -23.88 28.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.177 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.59 -36.71 76.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.63 -40.86 33.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.265 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.3 OUTLIER -56.11 -29.48 60.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.302 178.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -54.62 -42.2 70.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.201 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -110.76 -10.88 14.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -77.07 145.2 73.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.216 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 36.9 Cg_exo -59.82 149.92 80.55 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.704 1.602 . . . . 0.0 111.174 173.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -54.8 -34.32 84.5 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.681 1.588 . . . . 0.0 111.2 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 94.8 p -74.4 -17.03 60.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.177 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -99.93 -0.97 38.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.267 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -60.39 -41.42 93.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.219 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.26 -32.44 71.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -71.25 -35.62 71.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.212 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 46.7 mm -75.1 -45.0 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.22 -38.33 79.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -55.64 -49.07 73.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.196 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.99 -35.09 79.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.254 -176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -79.92 -22.31 42.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.235 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 86.89 26.36 32.0 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 94.6 t -87.04 124.89 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.769 0.319 . . . . 0.0 111.254 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.4 p -97.17 -25.73 15.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.195 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -99.08 78.19 2.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.184 175.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.3 tp -62.21 -44.91 95.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.264 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.13 -37.19 86.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 -176.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -59.74 -40.74 97.0 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.8 mmt -72.38 -33.84 67.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.351 . . . . 0.0 111.214 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.11 -29.73 66.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.199 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.34 -34.94 48.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -87.15 -6.06 58.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.505 ' C ' HD21 ' A' ' 348' ' ' LEU . 5.8 tt -51.76 -57.57 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.2 176.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.499 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 179.925 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.813 0.34 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.2 160.12 30.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.189 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 79.1 t -61.83 -42.19 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.262 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -75.86 -22.37 56.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.23 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.25 -33.19 69.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 170.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.6 mt -70.24 -44.19 77.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.234 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 96.8 mt -60.62 -30.79 70.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.188 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -51.74 -40.47 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.209 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -108.3 -10.04 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -74.79 152.67 87.02 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.249 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 41.5 Cg_exo -57.84 132.27 48.83 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.753 1.635 . . . . 0.0 111.185 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 75.4 Cg_exo -54.6 -35.22 85.81 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.69 1.593 . . . . 0.0 111.208 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.1 p -75.12 -17.24 60.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -106.93 17.04 23.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.182 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -64.91 -32.6 74.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.218 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.92 -43.55 68.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.51 -40.51 93.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.88 -44.96 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.229 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.07 -57.14 12.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -70.31 -24.1 62.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.163 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -61.76 -30.18 70.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.179 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -104.83 9.92 34.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.279 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.4 18.88 67.73 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 85.8 t -96.1 125.08 49.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 111.173 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 58.6 p -102.01 -24.84 13.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.218 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -93.53 84.08 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.198 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 50.6 tp -64.93 -46.07 83.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.206 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.73 -34.77 76.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.167 -176.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -60.27 -38.25 94.28 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.7 mmt -74.47 -32.64 62.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.192 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 94.4 mt -73.01 -24.95 60.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.205 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.99 -35.0 74.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.31 -32.16 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.223 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.469 ' O ' HD21 ' A' ' 348' ' ' LEU . 4.3 tt -57.39 -55.49 34.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.489 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -178.988 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.829 0.347 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -75.08 -16.97 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.08 -56.13 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.19 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 -75.61 -19.53 59.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.157 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.24 -36.9 77.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.227 172.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.11 -42.68 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 171.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.45 -35.13 75.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.253 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -56.22 -40.2 73.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.261 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -98.1 4.39 49.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -100.65 156.73 34.85 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.69 152.52 64.54 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.7 1.6 . . . . 0.0 111.203 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -70.34 -18.09 34.5 Favored 'Trans proline' 0 C--N 1.327 -0.566 0 C-N-CA 121.67 1.58 . . . . 0.0 111.172 -172.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.9 p -77.63 -16.87 58.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.191 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -112.47 9.79 19.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.195 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -66.49 -35.69 80.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.277 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -72.16 -39.11 68.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.224 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.16 -39.05 89.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.171 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 93.0 mt -70.01 -49.92 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.11 -48.71 75.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.169 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -66.81 -28.7 68.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.218 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -65.04 -30.03 70.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -93.45 -9.37 38.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 88.7 17.94 55.66 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 88.0 t -93.75 124.83 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 111.183 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.4 p -100.43 -26.59 13.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.243 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -85.18 75.0 10.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.199 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.2 -43.37 95.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.63 -37.09 80.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -61.89 -38.76 96.54 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -72.11 -30.69 65.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 111.243 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.05 -26.13 59.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.154 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.81 -35.06 77.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.137 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.13 -32.37 50.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 173.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.676 ' C ' HD21 ' A' ' 348' ' ' LEU . 4.2 tt -54.95 -53.05 60.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 175.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.201 -1.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.203 -179.408 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.849 0.357 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -129.96 11.69 5.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.236 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.23 -20.39 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.212 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -65.28 -20.07 66.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.12 -33.48 73.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.238 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.2 mt -72.14 -39.53 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.261 170.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 329' ' ' TYR . 92.5 mt -67.4 -20.95 65.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.191 -178.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -52.37 -44.27 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.243 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -108.39 15.54 23.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.196 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -100.51 147.75 34.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.151 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 37.2 Cg_exo -60.77 145.6 98.7 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.705 1.604 . . . . 0.0 111.233 173.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 76.7 Cg_exo -53.95 -34.11 75.28 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.686 1.591 . . . . 0.0 111.216 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 92.0 p -71.64 -19.48 62.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.219 -175.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -100.02 -0.56 38.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.202 -174.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . 0.4 ' HA ' HD23 ' A' ' 321' ' ' LEU . 11.9 m-30 -58.77 -50.78 72.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 -178.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.99 -42.62 89.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.176 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.39 -38.03 84.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 86.9 mt -68.4 -46.47 80.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.202 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -54.86 -45.63 74.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.186 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -65.31 -30.04 70.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -70.3 -21.87 62.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -104.79 8.58 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.279 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.01 24.83 70.67 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 93.9 t -102.01 121.2 52.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.761 0.315 . . . . 0.0 111.241 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.5 p -102.9 -26.51 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.206 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -85.03 74.8 10.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.26 177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.73 -40.0 91.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.282 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.91 -35.76 82.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.217 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -65.14 -36.95 93.54 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -72.69 -38.09 67.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 111.151 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.86 -20.25 59.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.27 -42.3 65.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.21 -33.78 76.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.201 174.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.05 -48.49 68.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.505 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 178.86 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.803 0.335 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -76.61 160.0 29.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.207 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 78.9 t -63.75 -43.49 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.242 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -73.89 -21.59 60.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.211 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -72.11 -37.16 69.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 171.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.9 mt -65.05 -42.55 94.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 170.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.03 -34.19 77.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.236 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -57.27 -40.98 78.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -98.88 20.83 12.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.19 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -119.7 156.93 53.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.249 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.57 149.55 61.87 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.65 1.567 . . . . 0.0 111.14 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.47 -15.39 27.8 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.663 1.575 . . . . 0.0 111.266 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.0 p -78.69 -15.29 58.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.215 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.75 25.01 8.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.221 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -72.36 -36.15 68.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.198 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.57 -39.5 73.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.162 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.04 -38.0 89.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 91.3 mt -69.54 -51.78 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.199 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.47 -42.94 75.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -65.86 -29.88 70.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.252 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -75.57 -13.43 60.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.252 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -105.01 1.41 28.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.197 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.83 24.94 68.31 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 92.3 t -100.14 116.72 44.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.778 0.323 . . . . 0.0 111.154 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.8 p -95.9 -27.56 15.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.208 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -84.96 74.82 10.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.22 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 55.0 tp -64.27 -42.28 96.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.165 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.89 -36.32 80.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.253 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -60.54 -39.91 97.08 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.3 mmt -71.54 -32.42 68.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.204 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.09 -24.9 58.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.02 -35.01 74.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 172.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.08 -33.39 61.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.205 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.523 ' C ' HD21 ' A' ' 348' ' ' LEU . 4.7 tt -56.92 -55.15 38.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.5 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 -178.902 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.848 0.356 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -95.92 -19.76 19.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.256 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.409 ' O ' ' HG ' ' A' ' 321' ' ' LEU . 2.5 p -61.9 -46.0 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 -172.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -78.54 -18.28 54.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.273 -174.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.97 -35.25 62.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.262 171.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.4 mt -76.79 -36.55 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.191 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 317' ' ' VAL . 62.4 mt -55.33 -32.64 62.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.173 178.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.22 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -104.98 1.13 28.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.192 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -97.57 143.43 26.17 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.12 -176.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 31.8 Cg_exo -59.3 151.68 65.99 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.729 1.62 . . . . 0.0 111.203 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 75.7 Cg_exo -55.09 -35.16 89.82 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.757 1.638 . . . . 0.0 111.161 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.4 p -74.35 -18.23 60.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.244 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -100.05 1.12 42.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.248 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -53.54 -51.54 62.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.7 -42.03 99.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.247 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.05 -38.71 89.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 -175.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 33.6 mm -63.75 -41.96 94.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.261 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.35 90.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.193 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -64.22 -32.78 74.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -65.1 -26.74 68.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -102.64 -1.18 30.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.168 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.01 24.98 70.24 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 84.4 t -96.25 125.16 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 111.17 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.4 p -96.73 -25.46 15.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -84.96 74.86 10.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 63.8 tp -64.09 -44.29 92.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.2 -38.92 88.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 -176.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.74 -36.96 94.05 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.9 mmt -74.92 -28.94 60.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.83 0.348 . . . . 0.0 111.239 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.3 mt -74.89 -24.05 58.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -69.97 -30.33 67.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.244 171.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.59 -31.79 41.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.655 ' C ' HD21 ' A' ' 348' ' ' LEU . 3.9 tt -53.85 -59.24 4.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.165 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.201 -1.495 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.295 -178.269 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -109.95 22.6 15.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.207 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.1 -20.47 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.186 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -62.47 -22.71 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.54 -34.46 77.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.193 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.96 -41.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.192 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 3.8 mp -63.39 -26.92 68.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -54.18 -40.26 67.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.248 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -110.74 19.66 18.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.186 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -110.97 149.65 40.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 32.2 Cg_exo -57.99 154.56 38.26 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.765 1.643 . . . . 0.0 111.175 174.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.24 -21.7 47.68 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.743 1.629 . . . . 0.0 111.205 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.3 p -77.36 -16.31 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.259 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -99.85 -3.04 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.191 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -59.28 -50.47 73.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.216 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.82 -48.62 68.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.188 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -60.3 -54.35 46.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.23 -176.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 97.4 mt -56.98 -45.98 83.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.168 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.59 -45.31 77.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -65.32 -30.74 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.193 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -69.14 -22.32 63.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.245 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -104.79 5.54 33.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 77.89 24.12 65.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.2 t -98.88 122.71 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.8 p -104.5 -25.0 12.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.235 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -84.9 73.84 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.28 -39.41 89.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.168 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.54 -36.09 83.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.175 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.87 -41.1 97.62 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 36.8 mmt -66.78 -40.46 88.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 111.181 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.8 -26.27 59.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.75 -43.25 84.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 172.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -77.49 -20.73 53.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.525 ' C ' HD21 ' A' ' 348' ' ' LEU . 5.6 tt -64.94 -56.19 14.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 173.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.201 -1.484 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.183 -178.266 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.886 0.374 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -85.03 75.51 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.239 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 74.9 t -71.28 -30.29 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.201 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -55.03 -28.91 55.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.58 -35.13 78.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.219 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.12 -36.32 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.199 172.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 329' ' ' TYR . 68.7 mt -69.96 -20.1 63.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -52.16 -40.94 62.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -110.2 20.13 18.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.246 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -114.24 146.37 35.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.66 153.26 43.66 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.712 1.608 . . . . 0.0 111.172 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.16 -21.05 49.16 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.66 1.574 . . . . 0.0 111.201 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 95.4 p -76.97 -15.72 59.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -99.98 -1.84 36.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.223 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . 0.4 ' HA ' HD23 ' A' ' 321' ' ' LEU . 12.0 m-30 -60.37 -49.61 76.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.03 -48.02 75.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.235 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -60.81 -52.53 64.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 91.0 mt -57.16 -49.01 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.71 -46.83 77.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.191 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -63.01 -34.75 78.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.248 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.4 -24.61 66.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -98.63 3.01 47.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.145 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.17 22.03 61.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 97.9 t -104.95 113.18 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 111.184 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 78.0 p -95.74 -20.01 19.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -84.89 74.77 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.171 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.15 -39.82 90.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.159 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.37 -34.95 74.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.157 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -61.37 -43.62 99.12 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.3 mmt -67.45 -30.88 70.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 111.197 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.06 -31.84 61.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.231 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.9 -33.25 71.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.188 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -79.78 -28.0 40.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.178 174.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.4 tp -66.32 -48.62 69.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.224 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.199 -1.559 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.653 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.803 0.335 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -80.05 170.0 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 12.3 p -69.58 -37.23 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.203 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -84.44 -22.2 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.248 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.27 -41.91 84.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.258 174.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.49 -40.07 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.4 OUTLIER -53.71 -29.96 41.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.202 178.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -53.97 -45.27 71.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.196 176.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -102.5 -15.48 16.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.177 -173.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -82.07 152.09 67.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.232 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.422 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 87.5 Cg_endo -73.4 147.29 41.23 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.696 1.597 . . . . 0.0 111.175 175.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 76.9 Cg_exo -54.48 -31.28 68.22 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.735 1.623 . . . . 0.0 111.203 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.0 p -68.38 -19.86 64.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.208 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -116.92 23.57 11.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.174 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -70.16 -29.93 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.208 174.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -72.25 -35.16 68.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -71.89 -34.34 69.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.228 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.35 -45.47 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.01 77.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -53.85 -44.54 70.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -68.96 -27.59 65.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -95.19 -7.9 37.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.218 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 78.63 26.12 59.48 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.86 129.07 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 111.197 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 71.3 p -115.18 5.08 14.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.182 -176.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -130.33 91.93 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.204 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 83.2 mt -74.72 -23.76 58.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.23 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.16 -37.05 75.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.182 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -66.89 -35.31 89.37 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.7 mmt -74.67 -29.91 61.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.824 0.345 . . . . 0.0 111.219 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.88 -35.69 80.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.23 -34.04 74.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -75.07 -29.77 60.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.245 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 98.1 mt -74.36 -29.75 61.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.199 -1.56 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.18 179.331 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -56.02 -42.57 76.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.206 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.72 -45.08 79.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.189 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 92.9 mt -69.7 -40.11 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.6 -31.24 56.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.192 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -54.27 -42.69 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -110.42 -9.93 14.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 -173.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -80.77 151.4 70.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.08 155.33 61.65 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.692 1.595 . . . . 0.0 111.219 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.97 -20.15 45.14 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.723 1.615 . . . . 0.0 111.201 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.4 p -76.13 -19.92 58.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.244 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -109.23 8.8 25.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.205 -175.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -64.64 -33.85 76.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.173 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.88 -36.92 64.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.196 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -67.87 -34.27 76.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.195 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 42.2 mm -76.68 -47.8 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.176 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.61 72.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -65.81 -29.87 70.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.194 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -63.57 -31.19 72.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -100.4 1.91 41.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.218 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.59 56.72 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.52 117.41 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.221 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 80.7 p -99.98 -27.89 13.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -85.22 73.27 10.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.189 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.4 -38.93 88.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.75 -45.0 93.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.79 -38.42 95.56 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 62.9 tpp -64.21 -35.79 81.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 111.212 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.89 -26.36 49.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.02 -35.11 77.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.242 169.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.92 -27.78 57.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.8 tp -65.03 -51.2 62.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.164 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 -178.622 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.446 ' O ' ' HG ' ' A' ' 321' ' ' LEU . 10.0 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.739 0.305 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -81.09 -22.91 38.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.173 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.17 -30.44 67.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.187 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.0 mm -81.49 -41.31 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.273 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 317' ' ' VAL . 81.6 mt -60.1 -35.03 74.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.24 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 54.4 tpt85 -65.27 -30.03 70.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -104.99 -36.01 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -169.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -81.07 158.05 70.4 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.221 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.05 153.73 56.01 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.717 1.611 . . . . 0.0 111.181 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.62 -17.01 38.45 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.696 1.597 . . . . 0.0 111.221 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.5 p -75.4 -14.91 60.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -100.09 -4.01 30.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -60.03 -31.62 70.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 -170.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.2 -50.53 71.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.01 -28.84 55.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.228 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.54 -44.4 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.62 84.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.212 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -62.0 -30.83 71.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.189 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -64.91 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -103.2 5.26 37.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 76.97 21.25 74.5 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 89.8 t -86.19 125.84 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 111.197 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.1 p -100.47 -27.48 13.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -95.37 82.32 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.216 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 49.2 tp -59.69 -49.57 77.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.26 -34.42 73.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.188 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.12 95.63 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.8 mmt -75.95 -25.74 56.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 111.221 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 92.0 mt -74.6 -21.67 59.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.191 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.03 -23.8 48.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.202 169.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -74.6 -14.86 60.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.55 -27.03 64.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.213 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -179.473 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.807 0.337 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -81.4 -24.09 37.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.194 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -71.74 -40.14 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.3 mm -82.9 -48.59 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 79.7 mt -55.19 -33.51 63.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.14 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -54.79 -43.9 73.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.193 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -111.79 -7.48 14.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -170.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -76.19 156.56 83.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.01 149.02 91.98 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.708 1.605 . . . . 0.0 111.192 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.03 -20.05 38.81 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.668 1.578 . . . . 0.0 111.258 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.5 p -77.57 -15.33 59.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.226 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -100.08 -7.19 25.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 -173.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -61.26 -36.3 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 -169.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.97 -49.81 74.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -70.44 -34.85 72.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.223 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 87.9 mt -67.74 -51.69 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.45 79.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.216 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -66.73 -30.05 70.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.194 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -62.9 -30.17 71.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.213 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -96.5 2.84 52.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.39 24.84 69.67 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 91.0 t -102.55 123.29 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 111.215 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.0 p -100.74 -23.95 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.8 71.14 10.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.4 -40.07 77.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.34 -44.96 96.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.131 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -67.85 -39.21 89.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 54.0 tpp -65.04 -43.32 92.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.186 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.96 -33.28 65.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.219 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.0 -40.2 95.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.163 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.53 -35.29 79.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.214 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.09 -38.97 79.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.226 175.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--O 1.2 -1.537 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.255 179.081 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 70.9 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.749 0.309 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -73.53 -20.71 60.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.82 -34.52 62.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.95 -40.11 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.223 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 1.3 mp -67.63 -22.02 65.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.268 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -46.04 -50.05 15.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.189 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -105.37 6.0 32.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.198 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -83.77 146.41 49.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 32.7 Cg_exo -57.89 147.7 80.06 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.659 1.572 . . . . 0.0 111.196 172.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 78.2 Cg_exo -53.93 -34.77 77.84 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.666 1.577 . . . . 0.0 111.212 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 87.5 p -72.96 -20.06 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.252 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -99.85 0.37 41.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.216 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -56.19 -52.81 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.21 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.62 -40.28 66.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.257 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.84 -35.49 81.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.171 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 97.1 mt -78.66 -46.89 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.41 -39.07 72.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.188 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -63.61 -30.32 71.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -74.18 -16.47 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -100.22 -4.12 30.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.248 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 84.51 22.55 53.57 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 88.3 t -108.17 120.46 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 0.0 111.152 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.1 p -106.09 -16.72 14.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.189 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -85.12 76.66 10.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.195 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.95 -37.5 87.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.232 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.71 -39.71 85.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.58 -41.14 99.84 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -66.5 -36.36 82.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 111.195 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.86 -26.89 57.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.66 -35.43 70.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 172.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.77 -30.38 61.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.196 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 54.2 tp -72.64 -50.32 25.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.248 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.2 -1.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 -178.385 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.864 0.364 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 318' ' ' TRP . . . . . 0.413 ' CE2' ' HG3' ' A' ' 319' ' ' GLU . 53.1 p-90 -59.04 -30.05 67.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.223 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' GLU . . . . . 0.413 ' HG3' ' CE2' ' A' ' 318' ' ' TRP . 96.5 mt-10 -68.48 -46.45 69.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 175.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.55 -32.37 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -25.6 63.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -56.35 -44.81 80.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.214 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -105.92 -12.28 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -172.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -82.56 150.83 63.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.179 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.87 152.57 47.0 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.691 1.594 . . . . 0.0 111.233 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.86 -33.46 81.77 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.689 1.593 . . . . 0.0 111.206 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 95.2 p -71.96 -21.06 61.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.187 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -108.72 7.39 26.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.176 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -59.15 -45.09 91.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.246 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.83 -40.24 94.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.21 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -64.97 -38.87 92.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.17 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.9 mm -65.02 -44.4 95.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.265 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.36 81.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.232 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -62.35 -34.76 77.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.179 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.89 -25.16 63.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -103.83 -1.71 27.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.194 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.16 25.32 69.05 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.84 125.88 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.331 . . . . 0.0 111.179 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.6 p -102.78 -24.91 13.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.166 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -86.3 72.15 10.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.281 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.41 -34.88 79.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.38 -45.39 88.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.178 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -63.3 -35.78 92.52 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 36.7 mmt -65.05 -41.96 94.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 111.216 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.19 -31.5 67.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.27 -32.86 70.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.22 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -75.1 -34.85 61.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.62 -52.0 43.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.184 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.199 -1.554 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.139 -177.022 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.867 0.365 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -74.95 -20.83 59.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.272 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.37 -30.27 64.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.243 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 95.3 mt -72.45 -40.11 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.237 170.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 329' ' ' TYR . 96.2 mt -61.79 -25.64 67.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.208 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -55.04 -40.47 70.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.253 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -100.09 -30.03 12.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 -173.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -65.1 145.04 99.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.208 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 39.5 Cg_exo -59.3 151.79 65.21 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.722 1.614 . . . . 0.0 111.249 172.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.75 -24.48 61.88 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.716 1.611 . . . . 0.0 111.162 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 93.7 p -78.44 -18.48 54.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -100.03 0.48 41.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.276 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' TYR . . . . . 0.416 ' CD1' HD22 ' A' ' 321' ' ' LEU . 9.6 m-30 -60.01 -34.19 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.181 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.05 -42.93 88.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.58 -34.68 72.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.25 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 37.2 mm -64.39 -43.4 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.189 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.21 99.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.182 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -65.29 -30.03 70.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -65.08 -33.57 76.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.207 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -105.39 -8.55 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.88 25.21 53.55 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.6 t -81.68 125.03 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.749 0.309 . . . . 0.0 111.178 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.0 p -96.01 -24.66 16.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.189 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -97.84 70.69 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.23 -40.22 95.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.175 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.57 -36.68 85.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.27 -41.16 99.74 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 24.8 mmt -65.14 -34.98 79.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 0.0 111.221 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.08 -25.32 58.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.45 -34.48 65.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.221 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.27 -34.29 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.0 -47.69 67.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 175.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.54 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 179.051 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 76.0 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.828 0.347 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -66.15 -27.26 67.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.228 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.25 -40.06 89.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.233 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.45 -41.06 85.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.234 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.04 -30.49 71.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -52.27 -41.28 62.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.185 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -109.45 20.73 17.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -109.57 159.4 31.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.162 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.95 131.72 43.36 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.663 1.575 . . . . 0.0 111.237 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.69 -34.89 85.68 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.686 1.591 . . . . 0.0 111.182 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.4 p -72.86 -15.7 61.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.196 -174.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -104.75 5.48 33.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.207 -174.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -63.72 -38.2 90.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.204 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.31 -49.73 74.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.174 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.36 -39.25 81.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.258 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 93.5 mt -69.98 -50.06 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.51 -45.03 92.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.204 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -66.35 -32.9 74.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -63.52 -30.19 71.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.159 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -83.68 -11.8 56.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.205 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 96.97 18.59 28.99 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.54 122.76 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 111.239 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 70.2 p -95.02 -20.04 19.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.216 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -106.12 81.74 1.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.208 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.41 -50.71 72.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.64 -39.02 92.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.226 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.11 -38.57 96.16 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 59.8 tpp -70.14 -30.88 68.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.96 -22.51 49.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.173 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.22 -32.97 67.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.35 -31.55 70.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.47 HD23 ' C ' ' A' ' 348' ' ' LEU . 4.4 tt -62.98 -57.18 11.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.203 175.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.521 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.221 -179.124 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.803 0.335 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -79.61 -43.25 23.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.207 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.02 -32.08 70.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 41.9 mm -74.63 -44.02 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.226 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.4 OUTLIER -58.95 -28.38 66.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 -178.397 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -63.67 -29.77 70.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.142 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -113.19 -13.64 12.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.251 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -90.48 150.68 43.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.27 155.99 63.01 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.719 1.613 . . . . 0.0 111.19 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -70.68 -16.41 33.68 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.698 1.598 . . . . 0.0 111.243 -172.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 85.5 p -71.96 -21.85 61.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.242 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -105.49 0.32 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.166 -170.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -59.35 -34.63 72.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.08 -50.03 69.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.238 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.28 -35.22 71.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.175 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.69 -44.8 99.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.212 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -57.27 -43.07 82.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -62.68 -34.76 77.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.194 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -67.56 -24.88 65.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.239 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -100.03 3.45 44.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.226 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.76 24.75 73.67 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.6 t -97.69 119.24 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 111.232 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.0 p -98.89 -29.96 12.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.209 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -111.09 86.4 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.219 172.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 49.2 tp -66.67 -39.24 88.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.251 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.04 -47.85 84.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -68.39 -35.93 83.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 16.7 tpt -64.33 -41.26 96.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 111.266 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 98.4 mt -72.31 -33.77 67.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.207 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.8 -34.08 77.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.196 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -69.91 -42.15 73.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.228 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 98.6 mt -74.9 -32.38 61.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.166 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.199 -1.561 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.192 -179.276 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.731 0.301 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -55.17 -27.96 49.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.226 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.22 -36.37 83.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.235 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.0 mt -76.6 -40.88 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.205 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.66 -35.04 75.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.219 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -56.33 -38.6 71.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.222 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -104.74 19.37 20.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -116.81 149.34 43.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 31.3 Cg_exo -59.85 146.69 95.09 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.705 1.603 . . . . 0.0 111.215 175.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -54.94 -33.29 81.93 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.794 1.663 . . . . 0.0 111.153 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 92.9 p -71.22 -16.19 62.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 -174.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -100.04 -2.27 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -60.05 -44.97 94.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.248 -176.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.6 -36.76 70.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.255 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.63 -37.0 68.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.18 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 85.1 mt -66.1 -49.97 72.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.191 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.37 74.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.118 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -55.01 -45.78 75.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.217 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -60.8 -35.15 75.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -100.01 4.22 44.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.263 -173.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 74.69 25.15 70.55 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.6 122.02 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.377 . . . . 0.0 111.193 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 80.6 p -97.58 -23.59 15.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.218 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -97.86 71.88 2.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.5 -41.27 96.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -62.4 -39.3 92.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.38 -36.11 92.79 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -70.85 -31.79 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.145 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.6 mt -76.14 -25.18 55.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.24 -35.0 73.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.34 -31.15 60.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.645 HD23 ' C ' ' A' ' 348' ' ' LEU . 4.3 tt -55.88 -56.56 19.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.237 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.55 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.231 -178.77 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.811 0.339 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -58.61 -25.56 62.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.193 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.22 -34.84 79.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.189 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.48 -41.91 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.181 173.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.42 -33.4 74.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.461 ' HB2' ' HB2' ' A' ' 348' ' ' LEU . 37.1 ttm180 -53.87 -41.54 67.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.186 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -100.75 5.22 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.219 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -96.16 150.92 37.81 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 -176.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 38.1 Cg_exo -60.24 151.84 70.69 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.709 1.606 . . . . 0.0 111.21 173.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.49 -24.19 49.49 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.681 1.587 . . . . 0.0 111.197 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.8 p -78.41 -18.48 54.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -100.39 0.12 39.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.256 -173.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -57.58 -51.72 68.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.259 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.14 -43.83 77.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.204 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.04 -37.22 86.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.2 -174.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.0 -50.0 45.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.46 -42.57 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.3 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -65.66 -31.52 72.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.223 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.88 -18.93 62.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -102.02 5.93 40.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.216 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.06 23.75 73.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 89.8 t -99.64 116.05 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.836 0.35 . . . . 0.0 111.204 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.6 p -97.39 -28.35 14.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.248 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -85.05 75.47 10.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.159 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 65.5 tp -62.59 -46.14 89.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.26 -39.22 89.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -56.99 -38.78 87.39 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.4 mmt -74.99 -37.2 61.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.146 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.98 -28.2 69.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.236 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.01 -24.52 60.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -83.98 -33.51 24.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.208 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.55 ' C ' HD12 ' A' ' 348' ' ' LEU . 2.2 pp -78.62 -23.26 45.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.199 -1.576 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.172 179.285 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 75.4 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.823 0.344 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -63.53 -21.43 66.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.18 -173.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.04 -25.82 62.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 49.6 mm -90.01 -32.32 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.428 HD22 ' CD1' ' A' ' 329' ' ' TYR . 90.1 mt -59.32 -27.62 66.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.266 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -54.84 -43.24 72.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.14 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -107.68 -9.93 15.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 -173.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -77.58 148.25 76.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.226 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.02 143.75 95.77 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.725 1.617 . . . . 0.0 111.169 173.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.39 -21.11 41.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.699 1.599 . . . . 0.0 111.164 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 86.9 p -81.8 -20.5 39.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -100.64 -0.65 37.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.218 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' TYR . . . . . 0.428 ' CD1' HD22 ' A' ' 321' ' ' LEU . 6.2 m-30 -50.03 -51.45 42.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 -175.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.03 -42.97 63.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.179 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.07 -37.33 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.279 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 38.3 mm -58.8 -40.72 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.29 96.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -63.5 -29.96 71.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.292 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -62.0 -27.48 68.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.198 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -103.07 3.36 35.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.227 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 77.32 24.69 65.22 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 90.7 t -104.19 129.13 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 111.176 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.3 p -103.26 -20.12 14.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -84.9 75.42 10.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 64.0 tp -64.9 -40.52 95.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.163 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.33 -37.22 86.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.225 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -63.24 -37.76 95.39 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 39.0 mmt -71.93 -30.9 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.729 0.299 . . . . 0.0 111.195 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.66 -28.79 61.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.208 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.25 -35.76 74.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.226 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.21 -28.41 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.179 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 68.4 tp -65.08 -52.89 52.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.152 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.524 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 -178.628 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.704 0.288 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -85.12 -23.88 28.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.177 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.59 -36.71 76.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.63 -40.86 33.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.265 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.3 OUTLIER -56.11 -29.48 60.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.302 178.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -54.62 -42.2 70.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.201 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -110.76 -10.88 14.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -77.07 145.2 73.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.216 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 36.9 Cg_exo -59.82 149.92 80.55 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.704 1.602 . . . . 0.0 111.174 173.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -54.8 -34.32 84.5 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.681 1.588 . . . . 0.0 111.2 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 94.8 p -74.4 -17.03 60.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.177 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -99.93 -0.97 38.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.267 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -60.39 -41.42 93.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.219 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.26 -32.44 71.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -71.25 -35.62 71.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.212 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 46.7 mm -75.1 -45.0 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.22 -38.33 79.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -55.64 -49.07 73.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.196 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.99 -35.09 79.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.254 -176.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -79.92 -22.31 42.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.235 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 86.89 26.36 32.0 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 94.6 t -87.04 124.89 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.769 0.319 . . . . 0.0 111.254 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.4 p -97.17 -25.73 15.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.195 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -99.08 78.19 2.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.184 175.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.3 tp -62.21 -44.91 95.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.264 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.13 -37.19 86.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 -176.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -59.74 -40.74 97.0 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.8 mmt -72.38 -33.84 67.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.351 . . . . 0.0 111.214 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.11 -29.73 66.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.199 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.34 -34.94 48.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -87.15 -6.06 58.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.505 HD23 ' C ' ' A' ' 348' ' ' LEU . 5.8 tt -51.76 -57.57 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.2 176.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.499 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 179.925 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 79.1 t . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.836 0.351 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -75.86 -22.37 56.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.23 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.25 -33.19 69.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 170.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.6 mt -70.24 -44.19 77.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.234 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 96.8 mt -60.62 -30.79 70.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.188 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -51.74 -40.47 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.209 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -108.3 -10.04 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -74.79 152.67 87.02 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.249 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 41.5 Cg_exo -57.84 132.27 48.83 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.753 1.635 . . . . 0.0 111.185 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 75.4 Cg_exo -54.6 -35.22 85.81 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.69 1.593 . . . . 0.0 111.208 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.1 p -75.12 -17.24 60.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -106.93 17.04 23.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.182 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -64.91 -32.6 74.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.218 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.92 -43.55 68.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.51 -40.51 93.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.88 -44.96 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.229 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.07 -57.14 12.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -70.31 -24.1 62.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.163 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -61.76 -30.18 70.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.179 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -104.83 9.92 34.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.279 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.4 18.88 67.73 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 85.8 t -96.1 125.08 49.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 111.173 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 58.6 p -102.01 -24.84 13.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.218 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -93.53 84.08 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.198 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 50.6 tp -64.93 -46.07 83.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.206 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.73 -34.77 76.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.167 -176.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -60.27 -38.25 94.28 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.7 mmt -74.47 -32.64 62.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.192 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 94.4 mt -73.01 -24.95 60.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.205 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.99 -35.0 74.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.31 -32.16 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.223 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 348' ' ' LEU . 4.3 tt -57.39 -55.49 34.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.489 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -178.988 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 75.0 t . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.781 0.325 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 -75.61 -19.53 59.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.157 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.24 -36.9 77.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.227 172.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.11 -42.68 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 171.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.45 -35.13 75.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.253 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -56.22 -40.2 73.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.261 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -98.1 4.39 49.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -100.65 156.73 34.85 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.69 152.52 64.54 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.7 1.6 . . . . 0.0 111.203 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -70.34 -18.09 34.5 Favored 'Trans proline' 0 C--N 1.327 -0.566 0 C-N-CA 121.67 1.58 . . . . 0.0 111.172 -172.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.9 p -77.63 -16.87 58.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.191 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -112.47 9.79 19.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.195 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -66.49 -35.69 80.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.277 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -72.16 -39.11 68.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.224 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.16 -39.05 89.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.171 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 93.0 mt -70.01 -49.92 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.11 -48.71 75.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.169 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -66.81 -28.7 68.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.218 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -65.04 -30.03 70.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -93.45 -9.37 38.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 88.7 17.94 55.66 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 88.0 t -93.75 124.83 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 111.183 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.4 p -100.43 -26.59 13.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.243 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -85.18 75.0 10.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.199 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.2 -43.37 95.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.63 -37.09 80.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -61.89 -38.76 96.54 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -72.11 -30.69 65.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 111.243 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.05 -26.13 59.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.154 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.81 -35.06 77.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.137 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.13 -32.37 50.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 173.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.676 HD23 ' C ' ' A' ' 348' ' ' LEU . 4.2 tt -54.95 -53.05 60.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 175.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.201 -1.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.203 -179.408 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.826 0.346 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -65.28 -20.07 66.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.12 -33.48 73.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.238 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.2 mt -72.14 -39.53 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.261 170.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.4 -20.95 65.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.191 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -52.37 -44.27 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.243 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -108.39 15.54 23.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.196 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -100.51 147.75 34.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.151 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 37.2 Cg_exo -60.77 145.6 98.7 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.705 1.604 . . . . 0.0 111.233 173.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 76.7 Cg_exo -53.95 -34.11 75.28 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.686 1.591 . . . . 0.0 111.216 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 92.0 p -71.64 -19.48 62.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.219 -175.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -100.02 -0.56 38.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.202 -174.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -58.77 -50.78 72.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.99 -42.62 89.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.176 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.39 -38.03 84.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 86.9 mt -68.4 -46.47 80.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.202 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -54.86 -45.63 74.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.186 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -65.31 -30.04 70.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -70.3 -21.87 62.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -104.79 8.58 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.279 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.01 24.83 70.67 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 93.9 t -102.01 121.2 52.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.761 0.315 . . . . 0.0 111.241 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.5 p -102.9 -26.51 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.206 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -85.03 74.8 10.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.26 177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.73 -40.0 91.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.282 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.91 -35.76 82.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.217 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -65.14 -36.95 93.54 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -72.69 -38.09 67.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 111.151 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.86 -20.25 59.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.27 -42.3 65.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.21 -33.78 76.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.201 174.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.05 -48.49 68.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.505 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 178.86 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.789 0.328 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -73.89 -21.59 60.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.211 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -72.11 -37.16 69.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 171.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.9 mt -65.05 -42.55 94.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 170.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.03 -34.19 77.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.236 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -57.27 -40.98 78.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -98.88 20.83 12.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.19 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -119.7 156.93 53.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.249 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.57 149.55 61.87 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.65 1.567 . . . . 0.0 111.14 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.47 -15.39 27.8 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.663 1.575 . . . . 0.0 111.266 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.0 p -78.69 -15.29 58.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.215 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.75 25.01 8.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.221 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -72.36 -36.15 68.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.198 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.57 -39.5 73.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.162 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.04 -38.0 89.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 91.3 mt -69.54 -51.78 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.199 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.47 -42.94 75.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -65.86 -29.88 70.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.252 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -75.57 -13.43 60.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.252 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -105.01 1.41 28.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.197 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.83 24.94 68.31 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 92.3 t -100.14 116.72 44.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.778 0.323 . . . . 0.0 111.154 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.8 p -95.9 -27.56 15.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.208 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -84.96 74.82 10.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.22 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 55.0 tp -64.27 -42.28 96.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.165 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.89 -36.32 80.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.253 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -60.54 -39.91 97.08 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.3 mmt -71.54 -32.42 68.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.204 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.09 -24.9 58.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.02 -35.01 74.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 172.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.08 -33.39 61.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.205 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.524 HD23 ' C ' ' A' ' 348' ' ' LEU . 4.7 tt -56.92 -55.15 38.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.5 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 -178.902 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 321' ' ' LEU . 2.5 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -78.54 -18.28 54.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.273 -174.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.97 -35.25 62.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.262 171.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.4 mt -76.79 -36.55 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.191 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 317' ' ' VAL . 62.4 mt -55.33 -32.64 62.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.173 178.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.22 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -104.98 1.13 28.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.192 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -97.57 143.43 26.17 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.12 -176.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.434 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 31.8 Cg_exo -59.3 151.68 65.99 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.729 1.62 . . . . 0.0 111.203 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 75.7 Cg_exo -55.09 -35.16 89.82 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.757 1.638 . . . . 0.0 111.161 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.4 p -74.35 -18.23 60.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.244 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -100.05 1.12 42.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.248 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -53.54 -51.54 62.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.7 -42.03 99.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.247 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.05 -38.71 89.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 -175.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 33.6 mm -63.75 -41.96 94.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.261 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.35 90.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.193 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -64.22 -32.78 74.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -65.1 -26.74 68.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -102.64 -1.18 30.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.168 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.01 24.98 70.24 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 84.4 t -96.25 125.16 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 111.17 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.4 p -96.73 -25.46 15.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -84.96 74.86 10.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 63.8 tp -64.09 -44.29 92.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.2 -38.92 88.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 -176.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.74 -36.96 94.05 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.9 mmt -74.92 -28.94 60.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.83 0.348 . . . . 0.0 111.239 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.3 mt -74.89 -24.05 58.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -69.97 -30.33 67.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.244 171.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.59 -31.79 41.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.657 HD23 ' C ' ' A' ' 348' ' ' LEU . 3.9 tt -53.85 -59.24 4.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.165 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.201 -1.495 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.295 -178.269 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.798 0.333 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 318' ' ' TRP . . . . . 0.422 ' HA ' ' HB2' ' A' ' 321' ' ' LEU . 65.1 p-90 -62.47 -22.71 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.54 -34.46 77.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.193 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.96 -41.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.192 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 318' ' ' TRP . 3.8 mp -63.39 -26.92 68.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -54.18 -40.26 67.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.248 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -110.74 19.66 18.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.186 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -110.97 149.65 40.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 32.2 Cg_exo -57.99 154.56 38.26 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.765 1.643 . . . . 0.0 111.175 174.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.24 -21.7 47.68 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.743 1.629 . . . . 0.0 111.205 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.3 p -77.36 -16.31 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.259 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -99.85 -3.04 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.191 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -59.28 -50.47 73.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.216 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.82 -48.62 68.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.188 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -60.3 -54.35 46.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.23 -176.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 97.4 mt -56.98 -45.98 83.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.168 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.59 -45.31 77.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -65.32 -30.74 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.193 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -69.14 -22.32 63.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.245 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -104.79 5.54 33.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 77.89 24.12 65.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.2 t -98.88 122.71 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.8 p -104.5 -25.0 12.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.235 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -84.9 73.84 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.28 -39.41 89.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.168 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.54 -36.09 83.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.175 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.87 -41.1 97.62 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 36.8 mmt -66.78 -40.46 88.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 111.181 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.8 -26.27 59.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.75 -43.25 84.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 172.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -77.49 -20.73 53.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.524 HD23 ' C ' ' A' ' 348' ' ' LEU . 5.6 tt -64.94 -56.19 14.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 173.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.201 -1.484 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.183 -178.266 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 74.9 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.815 0.341 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -55.03 -28.91 55.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.58 -35.13 78.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.219 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.12 -36.32 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.199 172.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 329' ' ' TYR . 68.7 mt -69.96 -20.1 63.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -52.16 -40.94 62.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -110.2 20.13 18.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.246 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -114.24 146.37 35.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.66 153.26 43.66 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.712 1.608 . . . . 0.0 111.172 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.16 -21.05 49.16 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.66 1.574 . . . . 0.0 111.201 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 95.4 p -76.97 -15.72 59.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -99.98 -1.84 36.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.223 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' TYR . . . . . 0.404 ' HA ' HD22 ' A' ' 321' ' ' LEU . 12.0 m-30 -60.37 -49.61 76.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.03 -48.02 75.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.235 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -60.81 -52.53 64.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 91.0 mt -57.16 -49.01 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.71 -46.83 77.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.191 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -63.01 -34.75 78.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.248 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.4 -24.61 66.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -98.63 3.01 47.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.145 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.17 22.03 61.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 97.9 t -104.95 113.18 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 111.184 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 78.0 p -95.74 -20.01 19.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -84.89 74.77 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.171 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.15 -39.82 90.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.159 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.37 -34.95 74.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.157 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -61.37 -43.62 99.12 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.3 mmt -67.45 -30.88 70.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 111.197 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.06 -31.84 61.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.231 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.9 -33.25 71.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.188 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -79.78 -28.0 40.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.178 174.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.4 tp -66.32 -48.62 69.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.224 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.199 -1.559 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.653 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.837 0.351 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 318' ' ' TRP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 321' ' ' LEU . 69.2 p-90 -84.44 -22.2 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.248 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.27 -41.91 84.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.258 174.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.49 -40.07 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.4 OUTLIER -53.71 -29.96 41.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.202 178.388 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -53.97 -45.27 71.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.196 176.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -102.5 -15.48 16.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.177 -173.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -82.07 152.09 67.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.232 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 87.5 Cg_endo -73.4 147.29 41.23 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.696 1.597 . . . . 0.0 111.175 175.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 76.9 Cg_exo -54.48 -31.28 68.22 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.735 1.623 . . . . 0.0 111.203 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.0 p -68.38 -19.86 64.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.208 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -116.92 23.57 11.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.174 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -70.16 -29.93 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.208 174.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -72.25 -35.16 68.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -71.89 -34.34 69.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.228 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.35 -45.47 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.01 77.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -53.85 -44.54 70.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -68.96 -27.59 65.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -95.19 -7.9 37.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.218 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 78.63 26.12 59.48 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.86 129.07 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 111.197 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 71.3 p -115.18 5.08 14.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.182 -176.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -130.33 91.93 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.204 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 83.2 mt -74.72 -23.76 58.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.23 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.16 -37.05 75.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.182 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -66.89 -35.31 89.37 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.7 mmt -74.67 -29.91 61.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.824 0.345 . . . . 0.0 111.219 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.88 -35.69 80.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.23 -34.04 74.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -75.07 -29.77 60.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.245 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 98.1 mt -74.36 -29.75 61.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.199 -1.56 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.18 179.331 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -79.9 169.98 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.206 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 69.9 t -65.3 -49.67 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.23 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -56.02 -42.57 76.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.206 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.72 -45.08 79.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.189 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 92.9 mt -69.7 -40.11 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.6 -31.24 56.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.192 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -54.27 -42.69 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -110.42 -9.93 14.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 -173.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -80.77 151.4 70.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.08 155.33 61.65 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.692 1.595 . . . . 0.0 111.219 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.97 -20.15 45.14 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.723 1.615 . . . . 0.0 111.201 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.4 p -76.13 -19.92 58.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.244 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -109.23 8.8 25.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.205 -175.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -64.64 -33.85 76.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.173 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.88 -36.92 64.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.196 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -67.87 -34.27 76.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.195 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 42.2 mm -76.68 -47.8 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.176 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.61 72.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -65.81 -29.87 70.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.194 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -63.57 -31.19 72.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -100.4 1.91 41.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.218 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.59 56.72 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.52 117.41 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.221 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 80.7 p -99.98 -27.89 13.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -85.22 73.27 10.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.189 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.4 -38.93 88.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.75 -45.0 93.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.79 -38.42 95.56 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 62.9 tpp -64.21 -35.79 81.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 111.212 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.89 -26.36 49.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.02 -35.11 77.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.242 169.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.92 -27.78 57.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.8 tp -65.03 -51.2 62.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.164 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 -178.622 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.78 0.324 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -75.53 158.88 31.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.446 ' O ' ' HG ' ' A' ' 321' ' ' LEU . 10.0 p -62.63 -35.35 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.18 -176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -81.09 -22.91 38.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.173 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.17 -30.44 67.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.187 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.0 mm -81.49 -41.31 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.273 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 317' ' ' VAL . 81.6 mt -60.1 -35.03 74.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.24 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 54.4 tpt85 -65.27 -30.03 70.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -104.99 -36.01 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -169.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -81.07 158.05 70.4 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.221 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.05 153.73 56.01 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.717 1.611 . . . . 0.0 111.181 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.62 -17.01 38.45 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.696 1.597 . . . . 0.0 111.221 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.5 p -75.4 -14.91 60.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -100.09 -4.01 30.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -60.03 -31.62 70.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 -170.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.2 -50.53 71.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.01 -28.84 55.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.228 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.54 -44.4 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.62 84.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.212 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -62.0 -30.83 71.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.189 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -64.91 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -103.2 5.26 37.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 76.97 21.25 74.5 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 89.8 t -86.19 125.84 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 111.197 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.1 p -100.47 -27.48 13.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -95.37 82.32 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.216 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 49.2 tp -59.69 -49.57 77.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.26 -34.42 73.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.188 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.12 95.63 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.8 mmt -75.95 -25.74 56.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 111.221 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 92.0 mt -74.6 -21.67 59.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.191 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.03 -23.8 48.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.202 169.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -74.6 -14.86 60.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.55 -27.03 64.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.213 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -179.473 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -75.71 159.99 30.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.211 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.46 -34.54 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -81.4 -24.09 37.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.194 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -71.74 -40.14 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.3 mm -82.9 -48.59 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 79.7 mt -55.19 -33.51 63.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.14 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -54.79 -43.9 73.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.193 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -111.79 -7.48 14.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -170.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -76.19 156.56 83.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.01 149.02 91.98 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.708 1.605 . . . . 0.0 111.192 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.03 -20.05 38.81 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.668 1.578 . . . . 0.0 111.258 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.5 p -77.57 -15.33 59.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.226 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -100.08 -7.19 25.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 -173.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -61.26 -36.3 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 -169.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.97 -49.81 74.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -70.44 -34.85 72.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.223 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 87.9 mt -67.74 -51.69 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.45 79.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.216 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -66.73 -30.05 70.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.194 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -62.9 -30.17 71.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.213 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -96.5 2.84 52.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.39 24.84 69.67 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 91.0 t -102.55 123.29 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 111.215 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.0 p -100.74 -23.95 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.8 71.14 10.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.4 -40.07 77.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.34 -44.96 96.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.131 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -67.85 -39.21 89.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 54.0 tpp -65.04 -43.32 92.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.186 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.96 -33.28 65.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.219 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.0 -40.2 95.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.163 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.53 -35.29 79.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.214 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.09 -38.97 79.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.226 175.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--O 1.2 -1.537 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.255 179.081 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 CA--C 1.523 -0.093 0 CA-C-O 120.838 0.352 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -79.83 169.94 17.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.189 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 70.9 t -68.23 -46.13 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.156 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -73.53 -20.71 60.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.82 -34.52 62.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.95 -40.11 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.223 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 1.3 mp -67.63 -22.02 65.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.268 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -46.04 -50.05 15.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.189 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -105.37 6.0 32.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.198 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -83.77 146.41 49.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 32.7 Cg_exo -57.89 147.7 80.06 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.659 1.572 . . . . 0.0 111.196 172.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 78.2 Cg_exo -53.93 -34.77 77.84 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.666 1.577 . . . . 0.0 111.212 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 87.5 p -72.96 -20.06 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.252 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -99.85 0.37 41.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.216 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -56.19 -52.81 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.21 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.62 -40.28 66.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.257 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.84 -35.49 81.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.171 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 97.1 mt -78.66 -46.89 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.41 -39.07 72.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.188 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -63.61 -30.32 71.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -74.18 -16.47 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -100.22 -4.12 30.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.248 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 84.51 22.55 53.57 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 88.3 t -108.17 120.46 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 0.0 111.152 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.1 p -106.09 -16.72 14.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.189 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -85.12 76.66 10.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.195 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.95 -37.5 87.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.232 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.71 -39.71 85.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.58 -41.14 99.84 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -66.5 -36.36 82.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 111.195 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.86 -26.89 57.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.66 -35.43 70.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 172.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.77 -30.38 61.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.196 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 54.2 tp -72.64 -50.32 25.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.248 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.2 -1.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 -178.385 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.783 0.325 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -76.15 162.48 27.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.22 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.33 -53.76 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.209 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' TRP . . . . . 0.413 ' CE2' ' HG3' ' A' ' 319' ' ' GLU . 53.1 p-90 -59.04 -30.05 67.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.223 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.413 ' HG3' ' CE2' ' A' ' 318' ' ' TRP . 96.5 mt-10 -68.48 -46.45 69.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 175.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.55 -32.37 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -25.6 63.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -56.35 -44.81 80.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.214 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -105.92 -12.28 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -172.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -82.56 150.83 63.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.179 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.87 152.57 47.0 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.691 1.594 . . . . 0.0 111.233 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.86 -33.46 81.77 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.689 1.593 . . . . 0.0 111.206 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 95.2 p -71.96 -21.06 61.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.187 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -108.72 7.39 26.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.176 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -59.15 -45.09 91.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.246 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.83 -40.24 94.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.21 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -64.97 -38.87 92.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.17 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.9 mm -65.02 -44.4 95.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.265 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.36 81.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.232 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -62.35 -34.76 77.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.179 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.89 -25.16 63.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -103.83 -1.71 27.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.194 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.16 25.32 69.05 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.84 125.88 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.331 . . . . 0.0 111.179 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.6 p -102.78 -24.91 13.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.166 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -86.3 72.15 10.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.281 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.41 -34.88 79.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.38 -45.39 88.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.178 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -63.3 -35.78 92.52 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 36.7 mmt -65.05 -41.96 94.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 111.216 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.19 -31.5 67.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.27 -32.86 70.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.22 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -75.1 -34.85 61.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.62 -52.0 43.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.184 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.199 -1.554 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.139 -177.022 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.741 0.305 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -77.89 170.02 17.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.162 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.53 -50.42 80.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.259 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -74.95 -20.83 59.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.272 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.37 -30.27 64.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.243 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 95.3 mt -72.45 -40.11 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.237 170.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 329' ' ' TYR . 96.2 mt -61.79 -25.64 67.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.208 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -55.04 -40.47 70.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.253 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -100.09 -30.03 12.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 -173.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -65.1 145.04 99.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.208 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 39.5 Cg_exo -59.3 151.79 65.21 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.722 1.614 . . . . 0.0 111.249 172.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.75 -24.48 61.88 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.716 1.611 . . . . 0.0 111.162 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 93.7 p -78.44 -18.48 54.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -100.03 0.48 41.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.276 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' TYR . . . . . 0.416 ' CD1' HD22 ' A' ' 321' ' ' LEU . 9.6 m-30 -60.01 -34.19 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.181 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.05 -42.93 88.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.58 -34.68 72.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.25 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 37.2 mm -64.39 -43.4 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.189 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.21 99.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.182 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -65.29 -30.03 70.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -65.08 -33.57 76.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.207 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -105.39 -8.55 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.88 25.21 53.55 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.6 t -81.68 125.03 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.749 0.309 . . . . 0.0 111.178 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.0 p -96.01 -24.66 16.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.189 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -97.84 70.69 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.23 -40.22 95.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.175 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.57 -36.68 85.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.27 -41.16 99.74 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 24.8 mmt -65.14 -34.98 79.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 0.0 111.221 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.08 -25.32 58.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.45 -34.48 65.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.221 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.27 -34.29 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.0 -47.69 67.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 175.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.54 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 179.051 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.795 0.331 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -75.02 160.55 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.49 -51.13 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -66.15 -27.26 67.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.228 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.25 -40.06 89.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.233 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.45 -41.06 85.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.234 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.04 -30.49 71.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -52.27 -41.28 62.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.185 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -109.45 20.73 17.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -109.57 159.4 31.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.162 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.95 131.72 43.36 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.663 1.575 . . . . 0.0 111.237 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.69 -34.89 85.68 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.686 1.591 . . . . 0.0 111.182 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.4 p -72.86 -15.7 61.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.196 -174.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -104.75 5.48 33.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.207 -174.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -63.72 -38.2 90.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.204 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.31 -49.73 74.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.174 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.36 -39.25 81.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.258 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 93.5 mt -69.98 -50.06 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.51 -45.03 92.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.204 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -66.35 -32.9 74.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -63.52 -30.19 71.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.159 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -83.68 -11.8 56.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.205 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 96.97 18.59 28.99 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.54 122.76 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 111.239 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 70.2 p -95.02 -20.04 19.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.216 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -106.12 81.74 1.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.208 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.41 -50.71 72.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.64 -39.02 92.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.226 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.11 -38.57 96.16 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 59.8 tpp -70.14 -30.88 68.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.96 -22.51 49.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.173 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.22 -32.97 67.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.35 -31.55 70.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.47 HD23 ' C ' ' A' ' 348' ' ' LEU . 4.4 tt -62.98 -57.18 11.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.203 175.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.521 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.221 -179.124 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.81 0.338 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -82.12 169.91 16.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.5 p -63.53 -30.35 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.176 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -79.61 -43.25 23.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.207 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.02 -32.08 70.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 41.9 mm -74.63 -44.02 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.226 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.4 OUTLIER -58.95 -28.38 66.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 -178.397 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -63.67 -29.77 70.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.142 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -113.19 -13.64 12.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.251 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -90.48 150.68 43.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.27 155.99 63.01 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.719 1.613 . . . . 0.0 111.19 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -70.68 -16.41 33.68 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.698 1.598 . . . . 0.0 111.243 -172.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 85.5 p -71.96 -21.85 61.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.242 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -105.49 0.32 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.166 -170.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -59.35 -34.63 72.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.08 -50.03 69.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.238 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.28 -35.22 71.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.175 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.69 -44.8 99.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.212 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -57.27 -43.07 82.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -62.68 -34.76 77.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.194 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -67.56 -24.88 65.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.239 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -100.03 3.45 44.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.226 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.76 24.75 73.67 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.6 t -97.69 119.24 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 111.232 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.0 p -98.89 -29.96 12.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.209 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -111.09 86.4 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.219 172.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 49.2 tp -66.67 -39.24 88.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.251 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.04 -47.85 84.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -68.39 -35.93 83.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 16.7 tpt -64.33 -41.26 96.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 111.266 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 98.4 mt -72.31 -33.77 67.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.207 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.8 -34.08 77.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.196 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -69.91 -42.15 73.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.228 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 98.6 mt -74.9 -32.38 61.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.166 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.199 -1.561 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.192 -179.276 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.824 0.345 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -110.12 44.85 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.196 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.24 -16.79 21.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.198 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -55.17 -27.96 49.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.226 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.22 -36.37 83.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.235 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.0 mt -76.6 -40.88 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.205 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.66 -35.04 75.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.219 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -56.33 -38.6 71.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.222 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -104.74 19.37 20.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -116.81 149.34 43.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 31.3 Cg_exo -59.85 146.69 95.09 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.705 1.603 . . . . 0.0 111.215 175.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -54.94 -33.29 81.93 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.794 1.663 . . . . 0.0 111.153 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 92.9 p -71.22 -16.19 62.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 -174.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -100.04 -2.27 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -60.05 -44.97 94.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.248 -176.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.6 -36.76 70.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.255 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.63 -37.0 68.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.18 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 85.1 mt -66.1 -49.97 72.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.191 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.37 74.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.118 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -55.01 -45.78 75.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.217 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -60.8 -35.15 75.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -100.01 4.22 44.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.263 -173.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 74.69 25.15 70.55 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.6 122.02 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.377 . . . . 0.0 111.193 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 80.6 p -97.58 -23.59 15.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.218 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -97.86 71.88 2.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.5 -41.27 96.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -62.4 -39.3 92.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.38 -36.11 92.79 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -70.85 -31.79 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.145 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.6 mt -76.14 -25.18 55.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.24 -35.0 73.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.34 -31.15 60.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.645 HD23 ' C ' ' A' ' 348' ' ' LEU . 4.3 tt -55.88 -56.56 19.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.237 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.55 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.231 -178.77 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.804 0.335 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -109.36 19.65 19.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.215 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.16 -22.88 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.21 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -58.61 -25.56 62.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.193 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.22 -34.84 79.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.189 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.48 -41.91 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.181 173.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.42 -33.4 74.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.461 ' HB2' ' HB2' ' A' ' 348' ' ' LEU . 37.1 ttm180 -53.87 -41.54 67.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.186 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -100.75 5.22 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.219 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -96.16 150.92 37.81 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 -176.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 38.1 Cg_exo -60.24 151.84 70.69 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.709 1.606 . . . . 0.0 111.21 173.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.49 -24.19 49.49 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.681 1.587 . . . . 0.0 111.197 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.8 p -78.41 -18.48 54.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -100.39 0.12 39.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.256 -173.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -57.58 -51.72 68.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.259 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.14 -43.83 77.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.204 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.04 -37.22 86.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.2 -174.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.0 -50.0 45.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.46 -42.57 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.3 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -65.66 -31.52 72.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.223 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.88 -18.93 62.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -102.02 5.93 40.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.216 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.06 23.75 73.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 89.8 t -99.64 116.05 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.836 0.35 . . . . 0.0 111.204 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.6 p -97.39 -28.35 14.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.248 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -85.05 75.47 10.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.159 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 65.5 tp -62.59 -46.14 89.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.26 -39.22 89.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -56.99 -38.78 87.39 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.4 mmt -74.99 -37.2 61.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.146 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.98 -28.2 69.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.236 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.01 -24.52 60.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -83.98 -33.51 24.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.208 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.55 ' C ' HD12 ' A' ' 348' ' ' LEU . 2.2 pp -78.62 -23.26 45.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.199 -1.576 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.172 179.285 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.404 ' HB3' ' CD1' ' A' ' 318' ' ' TRP . 92.2 m-20 -78.87 160.12 27.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.219 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.72 -45.94 80.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.266 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' TRP . . . . . 0.404 ' CD1' ' HB3' ' A' ' 316' ' ' ASP . 63.0 p-90 -63.53 -21.43 66.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.18 -173.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.04 -25.82 62.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 49.6 mm -90.01 -32.32 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.428 HD22 ' CD1' ' A' ' 329' ' ' TYR . 90.1 mt -59.32 -27.62 66.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.266 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -54.84 -43.24 72.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.14 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -107.68 -9.93 15.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 -173.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -77.58 148.25 76.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.226 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.02 143.75 95.77 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.725 1.617 . . . . 0.0 111.169 173.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.39 -21.11 41.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.699 1.599 . . . . 0.0 111.164 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 86.9 p -81.8 -20.5 39.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -100.64 -0.65 37.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.218 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' TYR . . . . . 0.428 ' CD1' HD22 ' A' ' 321' ' ' LEU . 6.2 m-30 -50.03 -51.45 42.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 -175.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.03 -42.97 63.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.179 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.07 -37.33 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.279 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 38.3 mm -58.8 -40.72 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.29 96.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -63.5 -29.96 71.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.292 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -62.0 -27.48 68.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.198 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -103.07 3.36 35.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.227 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 77.32 24.69 65.22 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 90.7 t -104.19 129.13 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 111.176 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.3 p -103.26 -20.12 14.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -84.9 75.42 10.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 64.0 tp -64.9 -40.52 95.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.163 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.33 -37.22 86.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.225 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -63.24 -37.76 95.39 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 39.0 mmt -71.93 -30.9 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.729 0.299 . . . . 0.0 111.195 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.66 -28.79 61.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.208 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.25 -35.76 74.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.226 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.21 -28.41 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.179 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 68.4 tp -65.08 -52.89 52.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.152 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.524 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 -178.628 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.772 0.32 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.08 157.6 36.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.234 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.15 -35.61 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.213 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -85.12 -23.88 28.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.177 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.59 -36.71 76.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.63 -40.86 33.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.265 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.3 OUTLIER -56.11 -29.48 60.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.302 178.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -54.62 -42.2 70.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.201 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -110.76 -10.88 14.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -77.07 145.2 73.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.216 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 36.9 Cg_exo -59.82 149.92 80.55 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.704 1.602 . . . . 0.0 111.174 173.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -54.8 -34.32 84.5 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.681 1.588 . . . . 0.0 111.2 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 94.8 p -74.4 -17.03 60.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.177 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -99.93 -0.97 38.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.267 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -60.39 -41.42 93.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.219 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.26 -32.44 71.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -71.25 -35.62 71.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.212 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 46.7 mm -75.1 -45.0 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.22 -38.33 79.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -55.64 -49.07 73.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.196 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.99 -35.09 79.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.254 -176.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -79.92 -22.31 42.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.235 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 86.89 26.36 32.0 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 94.6 t -87.04 124.89 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.769 0.319 . . . . 0.0 111.254 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.4 p -97.17 -25.73 15.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.195 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -99.08 78.19 2.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.184 175.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.3 tp -62.21 -44.91 95.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.264 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.13 -37.19 86.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 -176.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -59.74 -40.74 97.0 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.8 mmt -72.38 -33.84 67.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.351 . . . . 0.0 111.214 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.11 -29.73 66.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.199 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.34 -34.94 48.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -87.15 -6.06 58.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.505 HD23 ' C ' ' A' ' 348' ' ' LEU . 5.8 tt -51.76 -57.57 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.2 176.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.499 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 179.925 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.813 0.34 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.2 160.12 30.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.189 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 79.1 t -61.83 -42.19 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.262 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -75.86 -22.37 56.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.23 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.25 -33.19 69.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 170.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.6 mt -70.24 -44.19 77.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.234 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 96.8 mt -60.62 -30.79 70.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.188 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -51.74 -40.47 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.209 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -108.3 -10.04 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -74.79 152.67 87.02 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.249 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 41.5 Cg_exo -57.84 132.27 48.83 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.753 1.635 . . . . 0.0 111.185 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 75.4 Cg_exo -54.6 -35.22 85.81 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.69 1.593 . . . . 0.0 111.208 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.1 p -75.12 -17.24 60.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -106.93 17.04 23.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.182 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -64.91 -32.6 74.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.218 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.92 -43.55 68.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.51 -40.51 93.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.88 -44.96 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.229 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.07 -57.14 12.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -70.31 -24.1 62.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.163 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -61.76 -30.18 70.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.179 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -104.83 9.92 34.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.279 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.4 18.88 67.73 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 85.8 t -96.1 125.08 49.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 111.173 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 58.6 p -102.01 -24.84 13.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.218 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -93.53 84.08 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.198 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 50.6 tp -64.93 -46.07 83.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.206 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.73 -34.77 76.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.167 -176.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -60.27 -38.25 94.28 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.7 mmt -74.47 -32.64 62.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.192 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 94.4 mt -73.01 -24.95 60.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.205 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.99 -35.0 74.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.31 -32.16 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.223 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 348' ' ' LEU . 4.3 tt -57.39 -55.49 34.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.489 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -178.988 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.829 0.347 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -75.08 -16.97 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.08 -56.13 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.19 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 -75.61 -19.53 59.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.157 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.24 -36.9 77.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.227 172.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.11 -42.68 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 171.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.45 -35.13 75.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.253 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -56.22 -40.2 73.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.261 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -98.1 4.39 49.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -100.65 156.73 34.85 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.69 152.52 64.54 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.7 1.6 . . . . 0.0 111.203 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -70.34 -18.09 34.5 Favored 'Trans proline' 0 C--N 1.327 -0.566 0 C-N-CA 121.67 1.58 . . . . 0.0 111.172 -172.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.9 p -77.63 -16.87 58.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.191 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -112.47 9.79 19.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.195 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -66.49 -35.69 80.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.277 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -72.16 -39.11 68.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.224 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.16 -39.05 89.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.171 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 93.0 mt -70.01 -49.92 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.11 -48.71 75.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.169 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -66.81 -28.7 68.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.218 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -65.04 -30.03 70.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -93.45 -9.37 38.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 88.7 17.94 55.66 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 88.0 t -93.75 124.83 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 111.183 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.4 p -100.43 -26.59 13.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.243 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -85.18 75.0 10.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.199 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.2 -43.37 95.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.63 -37.09 80.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -61.89 -38.76 96.54 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -72.11 -30.69 65.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 111.243 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.05 -26.13 59.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.154 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.81 -35.06 77.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.137 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.13 -32.37 50.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 173.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.676 HD23 ' C ' ' A' ' 348' ' ' LEU . 4.2 tt -54.95 -53.05 60.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 175.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.201 -1.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.203 -179.408 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.849 0.357 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -129.96 11.69 5.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.236 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.23 -20.39 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.212 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -65.28 -20.07 66.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.12 -33.48 73.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.238 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.2 mt -72.14 -39.53 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.261 170.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.4 -20.95 65.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.191 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -52.37 -44.27 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.243 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -108.39 15.54 23.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.196 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -100.51 147.75 34.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.151 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 37.2 Cg_exo -60.77 145.6 98.7 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.705 1.604 . . . . 0.0 111.233 173.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 76.7 Cg_exo -53.95 -34.11 75.28 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.686 1.591 . . . . 0.0 111.216 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 92.0 p -71.64 -19.48 62.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.219 -175.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -100.02 -0.56 38.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.202 -174.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -58.77 -50.78 72.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.99 -42.62 89.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.176 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.39 -38.03 84.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 86.9 mt -68.4 -46.47 80.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.202 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -54.86 -45.63 74.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.186 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -65.31 -30.04 70.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -70.3 -21.87 62.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -104.79 8.58 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.279 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.01 24.83 70.67 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 93.9 t -102.01 121.2 52.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.761 0.315 . . . . 0.0 111.241 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.5 p -102.9 -26.51 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.206 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -85.03 74.8 10.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.26 177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.73 -40.0 91.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.282 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.91 -35.76 82.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.217 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -65.14 -36.95 93.54 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -72.69 -38.09 67.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 111.151 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.86 -20.25 59.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.27 -42.3 65.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.21 -33.78 76.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.201 174.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.05 -48.49 68.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.505 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 178.86 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.803 0.335 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -76.61 160.0 29.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.207 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 78.9 t -63.75 -43.49 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.242 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -73.89 -21.59 60.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.211 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -72.11 -37.16 69.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 171.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.9 mt -65.05 -42.55 94.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 170.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.03 -34.19 77.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.236 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -57.27 -40.98 78.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -98.88 20.83 12.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.19 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -119.7 156.93 53.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.249 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.57 149.55 61.87 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.65 1.567 . . . . 0.0 111.14 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.47 -15.39 27.8 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.663 1.575 . . . . 0.0 111.266 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.0 p -78.69 -15.29 58.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.215 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.75 25.01 8.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.221 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -72.36 -36.15 68.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.198 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.57 -39.5 73.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.162 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.04 -38.0 89.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 91.3 mt -69.54 -51.78 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.199 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.47 -42.94 75.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -65.86 -29.88 70.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.252 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -75.57 -13.43 60.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.252 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -105.01 1.41 28.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.197 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.83 24.94 68.31 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 92.3 t -100.14 116.72 44.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.778 0.323 . . . . 0.0 111.154 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.8 p -95.9 -27.56 15.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.208 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -84.96 74.82 10.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.22 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 55.0 tp -64.27 -42.28 96.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.165 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.89 -36.32 80.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.253 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -60.54 -39.91 97.08 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.3 mmt -71.54 -32.42 68.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.204 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.09 -24.9 58.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.02 -35.01 74.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 172.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.08 -33.39 61.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.205 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.524 HD23 ' C ' ' A' ' 348' ' ' LEU . 4.7 tt -56.92 -55.15 38.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.5 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 -178.902 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.848 0.356 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -95.92 -19.76 19.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.256 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 321' ' ' LEU . 2.5 p -61.9 -46.0 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 -172.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -78.54 -18.28 54.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.273 -174.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.97 -35.25 62.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.262 171.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.4 mt -76.79 -36.55 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.191 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 317' ' ' VAL . 62.4 mt -55.33 -32.64 62.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.173 178.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.22 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -104.98 1.13 28.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.192 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -97.57 143.43 26.17 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.12 -176.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.434 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 31.8 Cg_exo -59.3 151.68 65.99 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.729 1.62 . . . . 0.0 111.203 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 75.7 Cg_exo -55.09 -35.16 89.82 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.757 1.638 . . . . 0.0 111.161 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.4 p -74.35 -18.23 60.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.244 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -100.05 1.12 42.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.248 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -53.54 -51.54 62.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.7 -42.03 99.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.247 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.05 -38.71 89.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 -175.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 33.6 mm -63.75 -41.96 94.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.261 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.35 90.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.193 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -64.22 -32.78 74.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -65.1 -26.74 68.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -102.64 -1.18 30.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.168 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.01 24.98 70.24 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 84.4 t -96.25 125.16 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 111.17 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.4 p -96.73 -25.46 15.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -84.96 74.86 10.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 63.8 tp -64.09 -44.29 92.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.2 -38.92 88.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 -176.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.74 -36.96 94.05 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.9 mmt -74.92 -28.94 60.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.83 0.348 . . . . 0.0 111.239 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.3 mt -74.89 -24.05 58.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -69.97 -30.33 67.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.244 171.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.59 -31.79 41.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.657 HD23 ' C ' ' A' ' 348' ' ' LEU . 3.9 tt -53.85 -59.24 4.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.165 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.201 -1.495 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.295 -178.269 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -109.95 22.6 15.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.207 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.1 -20.47 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.186 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' TRP . . . . . 0.422 ' HA ' ' HB2' ' A' ' 321' ' ' LEU . 65.1 p-90 -62.47 -22.71 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.54 -34.46 77.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.193 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.96 -41.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.192 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 318' ' ' TRP . 3.8 mp -63.39 -26.92 68.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -54.18 -40.26 67.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.248 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -110.74 19.66 18.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.186 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -110.97 149.65 40.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 32.2 Cg_exo -57.99 154.56 38.26 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.765 1.643 . . . . 0.0 111.175 174.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.24 -21.7 47.68 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.743 1.629 . . . . 0.0 111.205 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.3 p -77.36 -16.31 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.259 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -99.85 -3.04 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.191 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -59.28 -50.47 73.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.216 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.82 -48.62 68.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.188 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -60.3 -54.35 46.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.23 -176.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 97.4 mt -56.98 -45.98 83.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.168 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.59 -45.31 77.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -65.32 -30.74 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.193 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -69.14 -22.32 63.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.245 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -104.79 5.54 33.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 77.89 24.12 65.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.2 t -98.88 122.71 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.8 p -104.5 -25.0 12.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.235 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -84.9 73.84 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.28 -39.41 89.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.168 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.54 -36.09 83.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.175 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.87 -41.1 97.62 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 36.8 mmt -66.78 -40.46 88.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 111.181 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.8 -26.27 59.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.75 -43.25 84.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 172.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -77.49 -20.73 53.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.524 HD23 ' C ' ' A' ' 348' ' ' LEU . 5.6 tt -64.94 -56.19 14.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 173.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.201 -1.484 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.183 -178.266 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.886 0.374 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -85.03 75.51 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.239 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 74.9 t -71.28 -30.29 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.201 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -55.03 -28.91 55.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.58 -35.13 78.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.219 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.12 -36.32 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.199 172.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 329' ' ' TYR . 68.7 mt -69.96 -20.1 63.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -52.16 -40.94 62.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -110.2 20.13 18.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.246 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -114.24 146.37 35.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.66 153.26 43.66 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.712 1.608 . . . . 0.0 111.172 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.16 -21.05 49.16 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.66 1.574 . . . . 0.0 111.201 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 95.4 p -76.97 -15.72 59.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -99.98 -1.84 36.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.223 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' TYR . . . . . 0.404 ' HA ' HD22 ' A' ' 321' ' ' LEU . 12.0 m-30 -60.37 -49.61 76.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.03 -48.02 75.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.235 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -60.81 -52.53 64.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 91.0 mt -57.16 -49.01 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.71 -46.83 77.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.191 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -63.01 -34.75 78.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.248 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.4 -24.61 66.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -98.63 3.01 47.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.145 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.17 22.03 61.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 97.9 t -104.95 113.18 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 111.184 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 78.0 p -95.74 -20.01 19.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -84.89 74.77 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.171 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.15 -39.82 90.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.159 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.37 -34.95 74.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.157 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -61.37 -43.62 99.12 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.3 mmt -67.45 -30.88 70.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 111.197 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.06 -31.84 61.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.231 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.9 -33.25 71.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.188 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -79.78 -28.0 40.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.178 174.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.4 tp -66.32 -48.62 69.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.224 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.199 -1.559 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.653 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.803 0.335 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -80.05 170.0 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 12.3 p -69.58 -37.23 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.203 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' TRP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 321' ' ' LEU . 69.2 p-90 -84.44 -22.2 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.248 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.27 -41.91 84.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.258 174.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.49 -40.07 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.4 OUTLIER -53.71 -29.96 41.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.202 178.388 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -53.97 -45.27 71.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.196 176.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -102.5 -15.48 16.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.177 -173.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -82.07 152.09 67.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.232 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 87.5 Cg_endo -73.4 147.29 41.23 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.696 1.597 . . . . 0.0 111.175 175.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 76.9 Cg_exo -54.48 -31.28 68.22 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.735 1.623 . . . . 0.0 111.203 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.0 p -68.38 -19.86 64.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.208 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -116.92 23.57 11.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.174 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -70.16 -29.93 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.208 174.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -72.25 -35.16 68.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -71.89 -34.34 69.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.228 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.35 -45.47 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.01 77.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -53.85 -44.54 70.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -68.96 -27.59 65.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -95.19 -7.9 37.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.218 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 78.63 26.12 59.48 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.86 129.07 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 111.197 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 71.3 p -115.18 5.08 14.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.182 -176.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -130.33 91.93 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.204 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 83.2 mt -74.72 -23.76 58.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.23 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.16 -37.05 75.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.182 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -66.89 -35.31 89.37 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.7 mmt -74.67 -29.91 61.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.824 0.345 . . . . 0.0 111.219 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.88 -35.69 80.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.23 -34.04 74.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -75.07 -29.77 60.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.245 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 98.1 mt -74.36 -29.75 61.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.199 -1.56 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.18 179.331 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -56.02 -42.57 76.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.206 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.72 -45.08 79.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.189 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 92.9 mt -69.7 -40.11 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.6 -31.24 56.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.192 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -54.27 -42.69 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -110.42 -9.93 14.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 -173.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -80.77 151.4 70.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.08 155.33 61.65 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.692 1.595 . . . . 0.0 111.219 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.97 -20.15 45.14 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.723 1.615 . . . . 0.0 111.201 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.4 p -76.13 -19.92 58.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.244 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -109.23 8.8 25.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.205 -175.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -64.64 -33.85 76.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.173 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.88 -36.92 64.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.196 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -67.87 -34.27 76.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.195 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 42.2 mm -76.68 -47.8 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.176 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.61 72.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -65.81 -29.87 70.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.194 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -63.57 -31.19 72.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -100.4 1.91 41.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.218 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.59 56.72 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.52 117.41 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.221 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 80.7 p -99.98 -27.89 13.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -85.22 73.27 10.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.189 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.4 -38.93 88.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.75 -45.0 93.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.79 -38.42 95.56 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 62.9 tpp -64.21 -35.79 81.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 111.212 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.89 -26.36 49.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.02 -35.11 77.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.242 169.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.92 -27.78 57.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.8 tp -65.03 -51.2 62.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.164 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 -178.622 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.446 ' O ' ' HG ' ' A' ' 321' ' ' LEU . 10.0 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.739 0.305 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -81.09 -22.91 38.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.173 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.17 -30.44 67.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.187 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.0 mm -81.49 -41.31 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.273 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 317' ' ' VAL . 81.6 mt -60.1 -35.03 74.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.24 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 54.4 tpt85 -65.27 -30.03 70.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -104.99 -36.01 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -169.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -81.07 158.05 70.4 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.221 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.05 153.73 56.01 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.717 1.611 . . . . 0.0 111.181 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.62 -17.01 38.45 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.696 1.597 . . . . 0.0 111.221 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.5 p -75.4 -14.91 60.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -100.09 -4.01 30.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -60.03 -31.62 70.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 -170.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.2 -50.53 71.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.01 -28.84 55.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.228 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.54 -44.4 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.62 84.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.212 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -62.0 -30.83 71.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.189 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -64.91 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -103.2 5.26 37.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 76.97 21.25 74.5 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 89.8 t -86.19 125.84 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 111.197 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.1 p -100.47 -27.48 13.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -95.37 82.32 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.216 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 49.2 tp -59.69 -49.57 77.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.26 -34.42 73.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.188 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.12 95.63 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.8 mmt -75.95 -25.74 56.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 111.221 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 92.0 mt -74.6 -21.67 59.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.191 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.03 -23.8 48.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.202 169.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -74.6 -14.86 60.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.55 -27.03 64.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.213 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -179.473 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.807 0.337 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -81.4 -24.09 37.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.194 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -71.74 -40.14 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.3 mm -82.9 -48.59 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 79.7 mt -55.19 -33.51 63.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.14 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -54.79 -43.9 73.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.193 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -111.79 -7.48 14.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -170.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -76.19 156.56 83.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.01 149.02 91.98 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.708 1.605 . . . . 0.0 111.192 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.03 -20.05 38.81 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.668 1.578 . . . . 0.0 111.258 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.5 p -77.57 -15.33 59.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.226 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -100.08 -7.19 25.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 -173.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -61.26 -36.3 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 -169.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.97 -49.81 74.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -70.44 -34.85 72.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.223 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 87.9 mt -67.74 -51.69 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.45 79.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.216 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -66.73 -30.05 70.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.194 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -62.9 -30.17 71.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.213 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -96.5 2.84 52.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.39 24.84 69.67 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 91.0 t -102.55 123.29 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 111.215 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.0 p -100.74 -23.95 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.8 71.14 10.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.4 -40.07 77.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.34 -44.96 96.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.131 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -67.85 -39.21 89.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 54.0 tpp -65.04 -43.32 92.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.186 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.96 -33.28 65.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.219 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.0 -40.2 95.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.163 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.53 -35.29 79.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.214 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.09 -38.97 79.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.226 175.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--O 1.2 -1.537 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.255 179.081 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 70.9 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.749 0.309 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -73.53 -20.71 60.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.82 -34.52 62.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.95 -40.11 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.223 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 1.3 mp -67.63 -22.02 65.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.268 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -46.04 -50.05 15.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.189 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -105.37 6.0 32.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.198 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -83.77 146.41 49.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 32.7 Cg_exo -57.89 147.7 80.06 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.659 1.572 . . . . 0.0 111.196 172.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 78.2 Cg_exo -53.93 -34.77 77.84 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.666 1.577 . . . . 0.0 111.212 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 87.5 p -72.96 -20.06 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.252 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -99.85 0.37 41.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.216 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -56.19 -52.81 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.21 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.62 -40.28 66.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.257 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.84 -35.49 81.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.171 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 97.1 mt -78.66 -46.89 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.41 -39.07 72.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.188 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -63.61 -30.32 71.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -74.18 -16.47 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -100.22 -4.12 30.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.248 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 84.51 22.55 53.57 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 88.3 t -108.17 120.46 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 0.0 111.152 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.1 p -106.09 -16.72 14.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.189 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -85.12 76.66 10.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.195 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.95 -37.5 87.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.232 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.71 -39.71 85.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.58 -41.14 99.84 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -66.5 -36.36 82.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 111.195 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.86 -26.89 57.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.66 -35.43 70.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 172.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.77 -30.38 61.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.196 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 54.2 tp -72.64 -50.32 25.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.248 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.2 -1.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 -178.385 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.864 0.364 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . 0.413 ' CE2' ' HG3' ' A' ' 319' ' ' GLU . 53.1 p-90 -59.04 -30.05 67.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.223 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . 0.413 ' HG3' ' CE2' ' A' ' 318' ' ' TRP . 96.5 mt-10 -68.48 -46.45 69.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 175.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.55 -32.37 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -25.6 63.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -56.35 -44.81 80.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.214 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -105.92 -12.28 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -172.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -82.56 150.83 63.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.179 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.87 152.57 47.0 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.691 1.594 . . . . 0.0 111.233 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.86 -33.46 81.77 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.689 1.593 . . . . 0.0 111.206 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 95.2 p -71.96 -21.06 61.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.187 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -108.72 7.39 26.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.176 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -59.15 -45.09 91.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.246 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.83 -40.24 94.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.21 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -64.97 -38.87 92.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.17 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.9 mm -65.02 -44.4 95.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.265 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.36 81.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.232 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -62.35 -34.76 77.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.179 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.89 -25.16 63.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -103.83 -1.71 27.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.194 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.16 25.32 69.05 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.84 125.88 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.331 . . . . 0.0 111.179 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.6 p -102.78 -24.91 13.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.166 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -86.3 72.15 10.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.281 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.41 -34.88 79.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.38 -45.39 88.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.178 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -63.3 -35.78 92.52 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 36.7 mmt -65.05 -41.96 94.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 111.216 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.19 -31.5 67.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.27 -32.86 70.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.22 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -75.1 -34.85 61.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.62 -52.0 43.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.184 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.199 -1.554 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.139 -177.022 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.867 0.365 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -74.95 -20.83 59.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.272 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.37 -30.27 64.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.243 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 95.3 mt -72.45 -40.11 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.237 170.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 329' ' ' TYR . 96.2 mt -61.79 -25.64 67.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.208 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -55.04 -40.47 70.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.253 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -100.09 -30.03 12.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 -173.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -65.1 145.04 99.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.208 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 39.5 Cg_exo -59.3 151.79 65.21 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.722 1.614 . . . . 0.0 111.249 172.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.75 -24.48 61.88 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.716 1.611 . . . . 0.0 111.162 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 93.7 p -78.44 -18.48 54.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -100.03 0.48 41.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.276 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . 0.416 ' CD1' HD22 ' A' ' 321' ' ' LEU . 9.6 m-30 -60.01 -34.19 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.181 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.05 -42.93 88.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.58 -34.68 72.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.25 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 37.2 mm -64.39 -43.4 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.189 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.21 99.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.182 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -65.29 -30.03 70.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -65.08 -33.57 76.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.207 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -105.39 -8.55 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.88 25.21 53.55 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.6 t -81.68 125.03 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.749 0.309 . . . . 0.0 111.178 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.0 p -96.01 -24.66 16.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.189 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -97.84 70.69 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.23 -40.22 95.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.175 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.57 -36.68 85.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.27 -41.16 99.74 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 24.8 mmt -65.14 -34.98 79.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 0.0 111.221 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.08 -25.32 58.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.45 -34.48 65.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.221 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.27 -34.29 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.0 -47.69 67.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 175.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.54 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 179.051 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 76.0 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.828 0.347 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -66.15 -27.26 67.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.228 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.25 -40.06 89.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.233 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.45 -41.06 85.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.234 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.04 -30.49 71.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -52.27 -41.28 62.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.185 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -109.45 20.73 17.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -109.57 159.4 31.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.162 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.95 131.72 43.36 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.663 1.575 . . . . 0.0 111.237 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.69 -34.89 85.68 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.686 1.591 . . . . 0.0 111.182 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.4 p -72.86 -15.7 61.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.196 -174.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -104.75 5.48 33.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.207 -174.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -63.72 -38.2 90.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.204 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.31 -49.73 74.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.174 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.36 -39.25 81.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.258 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 93.5 mt -69.98 -50.06 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.51 -45.03 92.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.204 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -66.35 -32.9 74.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -63.52 -30.19 71.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.159 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -83.68 -11.8 56.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.205 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 96.97 18.59 28.99 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.54 122.76 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 111.239 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 70.2 p -95.02 -20.04 19.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.216 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -106.12 81.74 1.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.208 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.41 -50.71 72.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.64 -39.02 92.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.226 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.11 -38.57 96.16 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 59.8 tpp -70.14 -30.88 68.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.96 -22.51 49.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.173 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.22 -32.97 67.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.35 -31.55 70.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 348' ' ' LEU . 4.4 tt -62.98 -57.18 11.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.203 175.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.521 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.221 -179.124 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.803 0.335 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -79.61 -43.25 23.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.207 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.02 -32.08 70.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 41.9 mm -74.63 -44.02 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.226 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.4 OUTLIER -58.95 -28.38 66.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 -178.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -63.67 -29.77 70.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.142 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -113.19 -13.64 12.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.251 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -90.48 150.68 43.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.27 155.99 63.01 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.719 1.613 . . . . 0.0 111.19 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -70.68 -16.41 33.68 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.698 1.598 . . . . 0.0 111.243 -172.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 85.5 p -71.96 -21.85 61.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.242 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -105.49 0.32 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.166 -170.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -59.35 -34.63 72.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.08 -50.03 69.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.238 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.28 -35.22 71.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.175 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.69 -44.8 99.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.212 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -57.27 -43.07 82.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -62.68 -34.76 77.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.194 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -67.56 -24.88 65.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.239 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -100.03 3.45 44.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.226 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.76 24.75 73.67 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.6 t -97.69 119.24 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 111.232 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.0 p -98.89 -29.96 12.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.209 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -111.09 86.4 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.219 172.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 49.2 tp -66.67 -39.24 88.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.251 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.04 -47.85 84.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -68.39 -35.93 83.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 16.7 tpt -64.33 -41.26 96.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 111.266 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 98.4 mt -72.31 -33.77 67.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.207 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.8 -34.08 77.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.196 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -69.91 -42.15 73.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.228 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 98.6 mt -74.9 -32.38 61.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.166 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.199 -1.561 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.192 -179.276 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.731 0.301 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -55.17 -27.96 49.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.226 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.22 -36.37 83.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.235 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.0 mt -76.6 -40.88 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.205 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.66 -35.04 75.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.219 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -56.33 -38.6 71.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.222 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -104.74 19.37 20.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -116.81 149.34 43.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 31.3 Cg_exo -59.85 146.69 95.09 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.705 1.603 . . . . 0.0 111.215 175.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -54.94 -33.29 81.93 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.794 1.663 . . . . 0.0 111.153 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 92.9 p -71.22 -16.19 62.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 -174.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -100.04 -2.27 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -60.05 -44.97 94.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.248 -176.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.6 -36.76 70.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.255 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.63 -37.0 68.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.18 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 85.1 mt -66.1 -49.97 72.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.191 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.37 74.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.118 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -55.01 -45.78 75.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.217 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -60.8 -35.15 75.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -100.01 4.22 44.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.263 -173.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 74.69 25.15 70.55 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.6 122.02 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.377 . . . . 0.0 111.193 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 80.6 p -97.58 -23.59 15.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.218 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -97.86 71.88 2.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.5 -41.27 96.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -62.4 -39.3 92.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.38 -36.11 92.79 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -70.85 -31.79 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.145 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.6 mt -76.14 -25.18 55.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.24 -35.0 73.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.34 -31.15 60.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.645 ' C ' HD23 ' A' ' 348' ' ' LEU . 4.3 tt -55.88 -56.56 19.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.237 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.55 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.231 -178.77 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.811 0.339 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -58.61 -25.56 62.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.193 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.22 -34.84 79.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.189 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.48 -41.91 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.181 173.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.42 -33.4 74.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.461 ' HB2' ' HB2' ' A' ' 348' ' ' LEU . 37.1 ttm180 -53.87 -41.54 67.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.186 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -100.75 5.22 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.219 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -96.16 150.92 37.81 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 -176.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 38.1 Cg_exo -60.24 151.84 70.69 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.709 1.606 . . . . 0.0 111.21 173.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.49 -24.19 49.49 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.681 1.587 . . . . 0.0 111.197 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.8 p -78.41 -18.48 54.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -100.39 0.12 39.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.256 -173.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -57.58 -51.72 68.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.259 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.14 -43.83 77.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.204 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.04 -37.22 86.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.2 -174.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.0 -50.0 45.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.46 -42.57 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.3 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -65.66 -31.52 72.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.223 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.88 -18.93 62.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -102.02 5.93 40.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.216 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.06 23.75 73.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 89.8 t -99.64 116.05 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.836 0.35 . . . . 0.0 111.204 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.6 p -97.39 -28.35 14.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.248 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -85.05 75.47 10.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.159 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 65.5 tp -62.59 -46.14 89.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.26 -39.22 89.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -56.99 -38.78 87.39 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.4 mmt -74.99 -37.2 61.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.146 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.98 -28.2 69.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.236 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.01 -24.52 60.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -83.98 -33.51 24.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.208 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.55 ' C ' HD12 ' A' ' 348' ' ' LEU . 2.2 pp -78.62 -23.26 45.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.199 -1.576 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.172 179.285 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 75.4 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.823 0.344 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -63.53 -21.43 66.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.18 -173.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.04 -25.82 62.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 49.6 mm -90.01 -32.32 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.428 HD22 ' CD1' ' A' ' 329' ' ' TYR . 90.1 mt -59.32 -27.62 66.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.266 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -54.84 -43.24 72.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.14 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -107.68 -9.93 15.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 -173.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -77.58 148.25 76.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.226 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.02 143.75 95.77 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.725 1.617 . . . . 0.0 111.169 173.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.39 -21.11 41.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.699 1.599 . . . . 0.0 111.164 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 86.9 p -81.8 -20.5 39.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -100.64 -0.65 37.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.218 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . 0.428 ' CD1' HD22 ' A' ' 321' ' ' LEU . 6.2 m-30 -50.03 -51.45 42.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 -175.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.03 -42.97 63.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.179 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.07 -37.33 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.279 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 38.3 mm -58.8 -40.72 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.29 96.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -63.5 -29.96 71.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.292 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -62.0 -27.48 68.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.198 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -103.07 3.36 35.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.227 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 77.32 24.69 65.22 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 90.7 t -104.19 129.13 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 111.176 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.3 p -103.26 -20.12 14.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -84.9 75.42 10.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 64.0 tp -64.9 -40.52 95.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.163 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.33 -37.22 86.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.225 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -63.24 -37.76 95.39 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 39.0 mmt -71.93 -30.9 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.729 0.299 . . . . 0.0 111.195 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.66 -28.79 61.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.208 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.25 -35.76 74.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.226 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.21 -28.41 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.179 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 68.4 tp -65.08 -52.89 52.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.152 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.524 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 -178.628 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.704 0.288 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -85.12 -23.88 28.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.177 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.59 -36.71 76.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.63 -40.86 33.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.265 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.3 OUTLIER -56.11 -29.48 60.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.302 178.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -54.62 -42.2 70.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.201 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -110.76 -10.88 14.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -77.07 145.2 73.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.216 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 36.9 Cg_exo -59.82 149.92 80.55 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.704 1.602 . . . . 0.0 111.174 173.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -54.8 -34.32 84.5 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.681 1.588 . . . . 0.0 111.2 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 94.8 p -74.4 -17.03 60.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.177 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -99.93 -0.97 38.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.267 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -60.39 -41.42 93.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.219 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.26 -32.44 71.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -71.25 -35.62 71.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.212 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 46.7 mm -75.1 -45.0 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.22 -38.33 79.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -55.64 -49.07 73.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.196 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.99 -35.09 79.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.254 -176.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -79.92 -22.31 42.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.235 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 86.89 26.36 32.0 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 94.6 t -87.04 124.89 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.769 0.319 . . . . 0.0 111.254 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.4 p -97.17 -25.73 15.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.195 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -99.08 78.19 2.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.184 175.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.3 tp -62.21 -44.91 95.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.264 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.13 -37.19 86.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 -176.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -59.74 -40.74 97.0 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.8 mmt -72.38 -33.84 67.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.351 . . . . 0.0 111.214 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.11 -29.73 66.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.199 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.34 -34.94 48.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -87.15 -6.06 58.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.505 ' C ' HD23 ' A' ' 348' ' ' LEU . 5.8 tt -51.76 -57.57 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.2 176.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.499 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 179.925 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 79.1 t . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.836 0.351 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -75.86 -22.37 56.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.23 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.25 -33.19 69.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 170.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.6 mt -70.24 -44.19 77.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.234 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 96.8 mt -60.62 -30.79 70.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.188 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -51.74 -40.47 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.209 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -108.3 -10.04 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -74.79 152.67 87.02 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.249 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 41.5 Cg_exo -57.84 132.27 48.83 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.753 1.635 . . . . 0.0 111.185 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 75.4 Cg_exo -54.6 -35.22 85.81 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.69 1.593 . . . . 0.0 111.208 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.1 p -75.12 -17.24 60.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -106.93 17.04 23.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.182 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -64.91 -32.6 74.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.218 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.92 -43.55 68.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.51 -40.51 93.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.88 -44.96 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.229 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.07 -57.14 12.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -70.31 -24.1 62.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.163 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -61.76 -30.18 70.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.179 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -104.83 9.92 34.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.279 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.4 18.88 67.73 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 85.8 t -96.1 125.08 49.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 111.173 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 58.6 p -102.01 -24.84 13.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.218 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -93.53 84.08 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.198 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 50.6 tp -64.93 -46.07 83.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.206 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.73 -34.77 76.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.167 -176.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -60.27 -38.25 94.28 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.7 mmt -74.47 -32.64 62.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.192 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 94.4 mt -73.01 -24.95 60.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.205 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.99 -35.0 74.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.31 -32.16 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.223 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 348' ' ' LEU . 4.3 tt -57.39 -55.49 34.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.489 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -178.988 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 75.0 t . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.781 0.325 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 -75.61 -19.53 59.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.157 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.24 -36.9 77.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.227 172.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.11 -42.68 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 171.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.45 -35.13 75.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.253 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -56.22 -40.2 73.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.261 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -98.1 4.39 49.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -100.65 156.73 34.85 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.69 152.52 64.54 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.7 1.6 . . . . 0.0 111.203 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -70.34 -18.09 34.5 Favored 'Trans proline' 0 C--N 1.327 -0.566 0 C-N-CA 121.67 1.58 . . . . 0.0 111.172 -172.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.9 p -77.63 -16.87 58.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.191 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -112.47 9.79 19.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.195 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -66.49 -35.69 80.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.277 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -72.16 -39.11 68.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.224 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.16 -39.05 89.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.171 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 93.0 mt -70.01 -49.92 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.11 -48.71 75.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.169 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -66.81 -28.7 68.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.218 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -65.04 -30.03 70.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -93.45 -9.37 38.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 88.7 17.94 55.66 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 88.0 t -93.75 124.83 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 111.183 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.4 p -100.43 -26.59 13.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.243 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -85.18 75.0 10.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.199 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.2 -43.37 95.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.63 -37.09 80.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -61.89 -38.76 96.54 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -72.11 -30.69 65.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 111.243 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.05 -26.13 59.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.154 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.81 -35.06 77.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.137 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.13 -32.37 50.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 173.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.676 ' C ' HD23 ' A' ' 348' ' ' LEU . 4.2 tt -54.95 -53.05 60.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 175.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.201 -1.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.203 -179.408 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.826 0.346 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -65.28 -20.07 66.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.12 -33.48 73.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.238 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.2 mt -72.14 -39.53 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.261 170.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.4 -20.95 65.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.191 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -52.37 -44.27 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.243 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -108.39 15.54 23.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.196 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -100.51 147.75 34.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.151 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 37.2 Cg_exo -60.77 145.6 98.7 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.705 1.604 . . . . 0.0 111.233 173.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 76.7 Cg_exo -53.95 -34.11 75.28 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.686 1.591 . . . . 0.0 111.216 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 92.0 p -71.64 -19.48 62.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.219 -175.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -100.02 -0.56 38.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.202 -174.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -58.77 -50.78 72.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.99 -42.62 89.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.176 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.39 -38.03 84.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 86.9 mt -68.4 -46.47 80.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.202 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -54.86 -45.63 74.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.186 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -65.31 -30.04 70.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -70.3 -21.87 62.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -104.79 8.58 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.279 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.01 24.83 70.67 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 93.9 t -102.01 121.2 52.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.761 0.315 . . . . 0.0 111.241 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.5 p -102.9 -26.51 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.206 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -85.03 74.8 10.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.26 177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.73 -40.0 91.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.282 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.91 -35.76 82.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.217 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -65.14 -36.95 93.54 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -72.69 -38.09 67.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 111.151 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.86 -20.25 59.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.27 -42.3 65.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.21 -33.78 76.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.201 174.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.05 -48.49 68.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.505 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 178.86 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.789 0.328 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -73.89 -21.59 60.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.211 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -72.11 -37.16 69.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 171.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.9 mt -65.05 -42.55 94.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 170.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.03 -34.19 77.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.236 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -57.27 -40.98 78.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -98.88 20.83 12.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.19 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -119.7 156.93 53.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.249 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.57 149.55 61.87 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.65 1.567 . . . . 0.0 111.14 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.47 -15.39 27.8 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.663 1.575 . . . . 0.0 111.266 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.0 p -78.69 -15.29 58.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.215 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.75 25.01 8.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.221 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -72.36 -36.15 68.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.198 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.57 -39.5 73.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.162 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.04 -38.0 89.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 91.3 mt -69.54 -51.78 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.199 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.47 -42.94 75.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -65.86 -29.88 70.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.252 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -75.57 -13.43 60.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.252 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -105.01 1.41 28.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.197 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.83 24.94 68.31 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 92.3 t -100.14 116.72 44.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.778 0.323 . . . . 0.0 111.154 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.8 p -95.9 -27.56 15.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.208 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -84.96 74.82 10.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.22 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 55.0 tp -64.27 -42.28 96.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.165 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.89 -36.32 80.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.253 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -60.54 -39.91 97.08 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.3 mmt -71.54 -32.42 68.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.204 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.09 -24.9 58.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.02 -35.01 74.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 172.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.08 -33.39 61.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.205 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 348' ' ' LEU . 4.7 tt -56.92 -55.15 38.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.5 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 -178.902 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 321' ' ' LEU . 2.5 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -78.54 -18.28 54.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.273 -174.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.97 -35.25 62.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.262 171.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.4 mt -76.79 -36.55 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.191 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 317' ' ' VAL . 62.4 mt -55.33 -32.64 62.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.173 178.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.22 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -104.98 1.13 28.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.192 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -97.57 143.43 26.17 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.12 -176.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.434 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 31.8 Cg_exo -59.3 151.68 65.99 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.729 1.62 . . . . 0.0 111.203 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 75.7 Cg_exo -55.09 -35.16 89.82 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.757 1.638 . . . . 0.0 111.161 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.4 p -74.35 -18.23 60.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.244 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -100.05 1.12 42.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.248 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -53.54 -51.54 62.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.7 -42.03 99.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.247 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.05 -38.71 89.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 -175.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 33.6 mm -63.75 -41.96 94.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.261 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.35 90.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.193 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -64.22 -32.78 74.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -65.1 -26.74 68.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -102.64 -1.18 30.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.168 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.01 24.98 70.24 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 84.4 t -96.25 125.16 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 111.17 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.4 p -96.73 -25.46 15.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -84.96 74.86 10.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 63.8 tp -64.09 -44.29 92.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.2 -38.92 88.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 -176.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.74 -36.96 94.05 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.9 mmt -74.92 -28.94 60.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.83 0.348 . . . . 0.0 111.239 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.3 mt -74.89 -24.05 58.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -69.97 -30.33 67.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.244 171.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.59 -31.79 41.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.657 ' C ' HD23 ' A' ' 348' ' ' LEU . 3.9 tt -53.85 -59.24 4.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.165 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.201 -1.495 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.295 -178.269 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.798 0.333 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . 0.422 ' HA ' ' HB2' ' A' ' 321' ' ' LEU . 65.1 p-90 -62.47 -22.71 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.54 -34.46 77.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.193 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.96 -41.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.192 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 318' ' ' TRP . 3.8 mp -63.39 -26.92 68.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -54.18 -40.26 67.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.248 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -110.74 19.66 18.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.186 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -110.97 149.65 40.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 32.2 Cg_exo -57.99 154.56 38.26 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.765 1.643 . . . . 0.0 111.175 174.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.24 -21.7 47.68 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.743 1.629 . . . . 0.0 111.205 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.3 p -77.36 -16.31 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.259 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -99.85 -3.04 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.191 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -59.28 -50.47 73.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.216 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.82 -48.62 68.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.188 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -60.3 -54.35 46.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.23 -176.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 97.4 mt -56.98 -45.98 83.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.168 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.59 -45.31 77.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -65.32 -30.74 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.193 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -69.14 -22.32 63.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.245 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -104.79 5.54 33.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 77.89 24.12 65.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.2 t -98.88 122.71 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.8 p -104.5 -25.0 12.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.235 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -84.9 73.84 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.28 -39.41 89.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.168 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.54 -36.09 83.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.175 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.87 -41.1 97.62 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 36.8 mmt -66.78 -40.46 88.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 111.181 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.8 -26.27 59.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.75 -43.25 84.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 172.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -77.49 -20.73 53.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 348' ' ' LEU . 5.6 tt -64.94 -56.19 14.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 173.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.201 -1.484 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.183 -178.266 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 74.9 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.815 0.341 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -55.03 -28.91 55.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.58 -35.13 78.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.219 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.12 -36.32 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.199 172.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 329' ' ' TYR . 68.7 mt -69.96 -20.1 63.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -52.16 -40.94 62.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -110.2 20.13 18.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.246 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -114.24 146.37 35.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.66 153.26 43.66 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.712 1.608 . . . . 0.0 111.172 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.16 -21.05 49.16 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.66 1.574 . . . . 0.0 111.201 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 95.4 p -76.97 -15.72 59.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -99.98 -1.84 36.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.223 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . 0.404 ' HA ' HD22 ' A' ' 321' ' ' LEU . 12.0 m-30 -60.37 -49.61 76.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.03 -48.02 75.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.235 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -60.81 -52.53 64.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 91.0 mt -57.16 -49.01 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.71 -46.83 77.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.191 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -63.01 -34.75 78.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.248 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.4 -24.61 66.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -98.63 3.01 47.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.145 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.17 22.03 61.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 97.9 t -104.95 113.18 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 111.184 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 78.0 p -95.74 -20.01 19.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -84.89 74.77 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.171 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.15 -39.82 90.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.159 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.37 -34.95 74.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.157 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -61.37 -43.62 99.12 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.3 mmt -67.45 -30.88 70.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 111.197 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.06 -31.84 61.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.231 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.9 -33.25 71.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.188 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -79.78 -28.0 40.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.178 174.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.4 tp -66.32 -48.62 69.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.224 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.199 -1.559 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.653 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.837 0.351 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' TRP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 321' ' ' LEU . 69.2 p-90 -84.44 -22.2 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.248 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.27 -41.91 84.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.258 174.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.49 -40.07 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.4 OUTLIER -53.71 -29.96 41.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.202 178.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -53.97 -45.27 71.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.196 176.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -102.5 -15.48 16.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.177 -173.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -82.07 152.09 67.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.232 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 87.5 Cg_endo -73.4 147.29 41.23 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.696 1.597 . . . . 0.0 111.175 175.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 76.9 Cg_exo -54.48 -31.28 68.22 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.735 1.623 . . . . 0.0 111.203 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.0 p -68.38 -19.86 64.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.208 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -116.92 23.57 11.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.174 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -70.16 -29.93 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.208 174.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -72.25 -35.16 68.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -71.89 -34.34 69.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.228 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.35 -45.47 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.01 77.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -53.85 -44.54 70.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -68.96 -27.59 65.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -95.19 -7.9 37.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.218 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 78.63 26.12 59.48 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.86 129.07 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 111.197 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 71.3 p -115.18 5.08 14.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.182 -176.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -130.33 91.93 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.204 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 83.2 mt -74.72 -23.76 58.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.23 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.16 -37.05 75.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.182 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -66.89 -35.31 89.37 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.7 mmt -74.67 -29.91 61.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.824 0.345 . . . . 0.0 111.219 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.88 -35.69 80.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.23 -34.04 74.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -75.07 -29.77 60.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.245 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 98.1 mt -74.36 -29.75 61.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.199 -1.56 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.18 179.331 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -79.9 169.98 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.206 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 69.9 t -65.3 -49.67 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.23 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -56.02 -42.57 76.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.206 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.72 -45.08 79.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.189 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 92.9 mt -69.7 -40.11 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.197 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.6 -31.24 56.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.192 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -54.27 -42.69 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -110.42 -9.93 14.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.227 -173.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -80.77 151.4 70.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.08 155.33 61.65 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.692 1.595 . . . . 0.0 111.219 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.97 -20.15 45.14 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.723 1.615 . . . . 0.0 111.201 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.4 p -76.13 -19.92 58.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.244 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -109.23 8.8 25.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.205 -175.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -64.64 -33.85 76.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.173 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -73.88 -36.92 64.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.196 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -67.87 -34.27 76.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.195 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 42.2 mm -76.68 -47.8 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.176 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.61 72.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -65.81 -29.87 70.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.194 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -63.57 -31.19 72.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -100.4 1.91 41.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.218 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.59 56.72 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.52 117.41 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.221 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 80.7 p -99.98 -27.89 13.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -85.22 73.27 10.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.189 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.4 -38.93 88.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.75 -45.0 93.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.79 -38.42 95.56 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 62.9 tpp -64.21 -35.79 81.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.821 0.343 . . . . 0.0 111.212 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.89 -26.36 49.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.202 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.02 -35.11 77.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.242 169.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.92 -27.78 57.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.197 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.8 tp -65.03 -51.2 62.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.164 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.168 -178.622 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.78 0.324 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -75.53 158.88 31.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.446 ' O ' ' HG ' ' A' ' 321' ' ' LEU . 10.0 p -62.63 -35.35 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.18 -176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -81.09 -22.91 38.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.173 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.17 -30.44 67.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.187 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.0 mm -81.49 -41.31 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.273 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 317' ' ' VAL . 81.6 mt -60.1 -35.03 74.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.24 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 54.4 tpt85 -65.27 -30.03 70.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -104.99 -36.01 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -169.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -81.07 158.05 70.4 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.221 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.05 153.73 56.01 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.717 1.611 . . . . 0.0 111.181 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.62 -17.01 38.45 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.696 1.597 . . . . 0.0 111.221 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.5 p -75.4 -14.91 60.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.203 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -100.09 -4.01 30.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -60.03 -31.62 70.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 -170.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.2 -50.53 71.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.01 -28.84 55.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.228 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 85.0 mt -61.54 -44.4 98.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.172 176.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.62 84.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.212 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -62.0 -30.83 71.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.189 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -64.91 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -103.2 5.26 37.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.213 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 76.97 21.25 74.5 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 89.8 t -86.19 125.84 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 111.197 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.1 p -100.47 -27.48 13.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -95.37 82.32 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.216 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 49.2 tp -59.69 -49.57 77.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.26 -34.42 73.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.188 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.12 95.63 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.8 mmt -75.95 -25.74 56.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 111.221 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 92.0 mt -74.6 -21.67 59.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.191 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -78.03 -23.8 48.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.202 169.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -74.6 -14.86 60.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.55 -27.03 64.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.213 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -179.473 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.783 0.325 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -75.71 159.99 30.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.211 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.46 -34.54 68.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -81.4 -24.09 37.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.194 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -71.74 -40.14 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 50.3 mm -82.9 -48.59 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 79.7 mt -55.19 -33.51 63.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.14 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -54.79 -43.9 73.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.193 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -111.79 -7.48 14.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -170.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -76.19 156.56 83.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.169 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.01 149.02 91.98 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.708 1.605 . . . . 0.0 111.192 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.03 -20.05 38.81 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.668 1.578 . . . . 0.0 111.258 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.5 p -77.57 -15.33 59.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.226 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -100.08 -7.19 25.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 -173.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -61.26 -36.3 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 -169.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.97 -49.81 74.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.169 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -70.44 -34.85 72.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.223 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 87.9 mt -67.74 -51.69 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.45 79.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.216 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -66.73 -30.05 70.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.194 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -62.9 -30.17 71.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.213 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -96.5 2.84 52.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.39 24.84 69.67 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 91.0 t -102.55 123.29 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.799 0.333 . . . . 0.0 111.215 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.0 p -100.74 -23.95 14.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.8 71.14 10.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.226 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.4 -40.07 77.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.224 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.34 -44.96 96.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.131 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -67.85 -39.21 89.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 54.0 tpp -65.04 -43.32 92.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.186 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.96 -33.28 65.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.219 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.0 -40.2 95.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.163 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.53 -35.29 79.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.214 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.09 -38.97 79.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.226 175.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--O 1.2 -1.537 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.255 179.081 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 CA--C 1.523 -0.093 0 CA-C-O 120.838 0.352 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -79.83 169.94 17.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.189 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 70.9 t -68.23 -46.13 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.156 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -73.53 -20.71 60.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.82 -34.52 62.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.95 -40.11 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.223 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 1.3 mp -67.63 -22.02 65.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.268 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -46.04 -50.05 15.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.189 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -105.37 6.0 32.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.198 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -83.77 146.41 49.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.216 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 32.7 Cg_exo -57.89 147.7 80.06 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.659 1.572 . . . . 0.0 111.196 172.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 78.2 Cg_exo -53.93 -34.77 77.84 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.666 1.577 . . . . 0.0 111.212 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 87.5 p -72.96 -20.06 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.252 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -99.85 0.37 41.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.216 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -56.19 -52.81 63.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.21 177.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.62 -40.28 66.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.257 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.84 -35.49 81.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.171 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 97.1 mt -78.66 -46.89 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.41 -39.07 72.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.188 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -63.61 -30.32 71.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.207 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -74.18 -16.47 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -100.22 -4.12 30.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.248 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 84.51 22.55 53.57 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 88.3 t -108.17 120.46 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 0.0 111.152 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.1 p -106.09 -16.72 14.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.189 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -85.12 76.66 10.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.195 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.95 -37.5 87.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.232 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.71 -39.71 85.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.58 -41.14 99.84 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -66.5 -36.36 82.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 111.195 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.86 -26.89 57.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.66 -35.43 70.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 172.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.77 -30.38 61.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.196 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 54.2 tp -72.64 -50.32 25.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.248 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.2 -1.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 -178.385 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.783 0.325 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -76.15 162.48 27.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.22 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.33 -53.76 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.209 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . 0.413 ' CE2' ' HG3' ' A' ' 319' ' ' GLU . 53.1 p-90 -59.04 -30.05 67.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.223 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.413 ' HG3' ' CE2' ' A' ' 318' ' ' TRP . 96.5 mt-10 -68.48 -46.45 69.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.206 175.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.55 -32.37 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.99 -25.6 63.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.163 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -56.35 -44.81 80.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.214 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -105.92 -12.28 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -172.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -82.56 150.83 63.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.179 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.87 152.57 47.0 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.691 1.594 . . . . 0.0 111.233 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.86 -33.46 81.77 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.689 1.593 . . . . 0.0 111.206 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 95.2 p -71.96 -21.06 61.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.187 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -108.72 7.39 26.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.176 -175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -59.15 -45.09 91.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.246 177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.83 -40.24 94.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.21 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -64.97 -38.87 92.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.17 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.9 mm -65.02 -44.4 95.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.265 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.36 81.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.232 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -62.35 -34.76 77.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.179 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -69.89 -25.16 63.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.154 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -103.83 -1.71 27.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.194 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.16 25.32 69.05 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.84 125.88 45.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.331 . . . . 0.0 111.179 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.6 p -102.78 -24.91 13.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.166 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -86.3 72.15 10.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.281 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.41 -34.88 79.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.38 -45.39 88.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.178 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -63.3 -35.78 92.52 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 36.7 mmt -65.05 -41.96 94.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 111.216 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.19 -31.5 67.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.27 -32.86 70.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.22 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -75.1 -34.85 61.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.62 -52.0 43.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.184 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.199 -1.554 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.139 -177.022 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.741 0.305 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -77.89 170.02 17.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.162 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.53 -50.42 80.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.259 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -74.95 -20.83 59.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.272 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -72.37 -30.27 64.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.243 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 95.3 mt -72.45 -40.11 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.237 170.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 329' ' ' TYR . 96.2 mt -61.79 -25.64 67.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.208 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -55.04 -40.47 70.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.253 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -100.09 -30.03 12.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 -173.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -65.1 145.04 99.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.208 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 39.5 Cg_exo -59.3 151.79 65.21 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.722 1.614 . . . . 0.0 111.249 172.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.75 -24.48 61.88 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.716 1.611 . . . . 0.0 111.162 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 93.7 p -78.44 -18.48 54.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.212 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -100.03 0.48 41.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.276 -174.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . 0.416 ' CD1' HD22 ' A' ' 321' ' ' LEU . 9.6 m-30 -60.01 -34.19 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.181 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.05 -42.93 88.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.58 -34.68 72.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.25 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 37.2 mm -64.39 -43.4 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.189 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.21 99.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.182 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -65.29 -30.03 70.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.195 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -65.08 -33.57 76.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.207 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -105.39 -8.55 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.88 25.21 53.55 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.6 t -81.68 125.03 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.749 0.309 . . . . 0.0 111.178 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.0 p -96.01 -24.66 16.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.189 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -97.84 70.69 2.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.23 -40.22 95.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.175 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.57 -36.68 85.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.27 -41.16 99.74 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 24.8 mmt -65.14 -34.98 79.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.812 0.339 . . . . 0.0 111.221 175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.08 -25.32 58.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -73.45 -34.48 65.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.221 170.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.27 -34.29 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.0 -47.69 67.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 175.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.54 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 179.051 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.795 0.331 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -75.02 160.55 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.49 -51.13 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.167 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -66.15 -27.26 67.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.228 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.25 -40.06 89.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.233 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.45 -41.06 85.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.234 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 97.4 mt -65.04 -30.49 71.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -52.27 -41.28 62.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.185 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -109.45 20.73 17.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -109.57 159.4 31.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.162 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.95 131.72 43.36 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.663 1.575 . . . . 0.0 111.237 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.69 -34.89 85.68 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.686 1.591 . . . . 0.0 111.182 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.4 p -72.86 -15.7 61.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.196 -174.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -104.75 5.48 33.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.207 -174.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -63.72 -38.2 90.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.204 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.31 -49.73 74.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.174 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.36 -39.25 81.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.258 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 93.5 mt -69.98 -50.06 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.51 -45.03 92.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.204 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -66.35 -32.9 74.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -63.52 -30.19 71.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.159 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -83.68 -11.8 56.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.205 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 96.97 18.59 28.99 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.54 122.76 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 111.239 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 70.2 p -95.02 -20.04 19.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.216 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -106.12 81.74 1.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.208 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.41 -50.71 72.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.64 -39.02 92.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.226 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.11 -38.57 96.16 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 59.8 tpp -70.14 -30.88 68.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.96 -22.51 49.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.173 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.22 -32.97 67.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 168.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.35 -31.55 70.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 348' ' ' LEU . 4.4 tt -62.98 -57.18 11.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.203 175.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.521 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.221 -179.124 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.81 0.338 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -82.12 169.91 16.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.5 p -63.53 -30.35 49.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.176 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -79.61 -43.25 23.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.207 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -60.02 -32.08 70.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.209 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 41.9 mm -74.63 -44.02 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.226 173.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.4 OUTLIER -58.95 -28.38 66.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.193 -178.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -63.67 -29.77 70.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.142 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -113.19 -13.64 12.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.251 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -90.48 150.68 43.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.27 155.99 63.01 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.719 1.613 . . . . 0.0 111.19 175.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -70.68 -16.41 33.68 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.698 1.598 . . . . 0.0 111.243 -172.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 85.5 p -71.96 -21.85 61.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.242 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -105.49 0.32 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.166 -170.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -59.35 -34.63 72.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.08 -50.03 69.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.238 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.28 -35.22 71.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.175 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.69 -44.8 99.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.212 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -57.27 -43.07 82.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.184 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -62.68 -34.76 77.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.194 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -67.56 -24.88 65.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.239 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -100.03 3.45 44.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.226 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.76 24.75 73.67 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 96.6 t -97.69 119.24 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 111.232 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.0 p -98.89 -29.96 12.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.209 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -111.09 86.4 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.219 172.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 49.2 tp -66.67 -39.24 88.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.251 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.04 -47.85 84.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -68.39 -35.93 83.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 16.7 tpt -64.33 -41.26 96.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 111.266 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 98.4 mt -72.31 -33.77 67.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.207 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.8 -34.08 77.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.196 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -69.91 -42.15 73.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.228 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 98.6 mt -74.9 -32.38 61.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.166 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.199 -1.561 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.192 -179.276 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.824 0.345 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -110.12 44.85 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.196 177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.24 -16.79 21.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.198 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -55.17 -27.96 49.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.226 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.22 -36.37 83.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.235 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.0 mt -76.6 -40.88 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.205 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.66 -35.04 75.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.219 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -56.33 -38.6 71.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.222 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -104.74 19.37 20.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -116.81 149.34 43.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 31.3 Cg_exo -59.85 146.69 95.09 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.705 1.603 . . . . 0.0 111.215 175.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -54.94 -33.29 81.93 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.794 1.663 . . . . 0.0 111.153 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 92.9 p -71.22 -16.19 62.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.175 -174.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -100.04 -2.27 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 14.2 m-30 -60.05 -44.97 94.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.248 -176.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.6 -36.76 70.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.255 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.63 -37.0 68.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.18 -177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 85.1 mt -66.1 -49.97 72.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.191 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.37 74.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.118 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -55.01 -45.78 75.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.217 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -60.8 -35.15 75.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -175.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -100.01 4.22 44.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.263 -173.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 74.69 25.15 70.55 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.6 122.02 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.377 . . . . 0.0 111.193 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 80.6 p -97.58 -23.59 15.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.218 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -97.86 71.88 2.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.126 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.5 -41.27 96.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -62.4 -39.3 92.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.38 -36.11 92.79 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -70.85 -31.79 68.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.145 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.6 mt -76.14 -25.18 55.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -70.24 -35.0 73.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.145 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.34 -31.15 60.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.645 ' C ' HD23 ' A' ' 348' ' ' LEU . 4.3 tt -55.88 -56.56 19.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.237 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.55 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.231 -178.77 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.804 0.335 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -109.36 19.65 19.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.215 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.16 -22.88 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.21 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -58.61 -25.56 62.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.193 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.22 -34.84 79.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.189 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.48 -41.91 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.181 173.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.42 -33.4 74.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.155 -174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.461 ' HB2' ' HB2' ' A' ' 348' ' ' LEU . 37.1 ttm180 -53.87 -41.54 67.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.186 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -100.75 5.22 43.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.219 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -96.16 150.92 37.81 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.165 -176.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 38.1 Cg_exo -60.24 151.84 70.69 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.709 1.606 . . . . 0.0 111.21 173.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.49 -24.19 49.49 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.681 1.587 . . . . 0.0 111.197 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.8 p -78.41 -18.48 54.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -100.39 0.12 39.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.256 -173.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -57.58 -51.72 68.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.259 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.14 -43.83 77.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.204 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.04 -37.22 86.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.2 -174.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.0 -50.0 45.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.46 -42.57 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.3 -176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -65.66 -31.52 72.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.223 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.88 -18.93 62.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -102.02 5.93 40.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.216 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.06 23.75 73.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 89.8 t -99.64 116.05 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.836 0.35 . . . . 0.0 111.204 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.6 p -97.39 -28.35 14.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.248 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -85.05 75.47 10.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.159 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 65.5 tp -62.59 -46.14 89.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.26 -39.22 89.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -56.99 -38.78 87.39 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.4 mmt -74.99 -37.2 61.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.146 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.98 -28.2 69.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.236 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.01 -24.52 60.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -83.98 -33.51 24.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.208 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.55 ' C ' HD12 ' A' ' 348' ' ' LEU . 2.2 pp -78.62 -23.26 45.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.199 -1.576 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.172 179.285 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.772 0.32 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.404 ' HB3' ' CD1' ' A' ' 318' ' ' TRP . 92.2 m-20 -78.87 160.12 27.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.219 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.72 -45.94 80.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.266 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . 0.404 ' CD1' ' HB3' ' A' ' 316' ' ' ASP . 63.0 p-90 -63.53 -21.43 66.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.18 -173.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.04 -25.82 62.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 175.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 49.6 mm -90.01 -32.32 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.428 HD22 ' CD1' ' A' ' 329' ' ' TYR . 90.1 mt -59.32 -27.62 66.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.266 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -54.84 -43.24 72.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.14 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -107.68 -9.93 15.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 -173.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -77.58 148.25 76.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.226 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.02 143.75 95.77 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.725 1.617 . . . . 0.0 111.169 173.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.39 -21.11 41.37 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.699 1.599 . . . . 0.0 111.164 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 86.9 p -81.8 -20.5 39.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -100.64 -0.65 37.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.218 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . 0.428 ' CD1' HD22 ' A' ' 321' ' ' LEU . 6.2 m-30 -50.03 -51.45 42.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 -175.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.03 -42.97 63.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.179 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.07 -37.33 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.279 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 38.3 mm -58.8 -40.72 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.29 96.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -63.5 -29.96 71.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.292 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -62.0 -27.48 68.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.198 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -103.07 3.36 35.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.227 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 77.32 24.69 65.22 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 90.7 t -104.19 129.13 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 0.0 111.176 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.3 p -103.26 -20.12 14.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -84.9 75.42 10.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 64.0 tp -64.9 -40.52 95.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.163 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -63.33 -37.22 86.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.225 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -63.24 -37.76 95.39 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 39.0 mmt -71.93 -30.9 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.729 0.299 . . . . 0.0 111.195 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.66 -28.79 61.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.208 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.25 -35.76 74.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.226 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.21 -28.41 59.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.179 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 68.4 tp -65.08 -52.89 52.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.152 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.2 -1.524 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 -178.628 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.772 0.32 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.08 157.6 36.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.234 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.15 -35.61 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.213 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -85.12 -23.88 28.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.177 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.59 -36.71 76.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.63 -40.86 33.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.265 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.3 OUTLIER -56.11 -29.48 60.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.302 178.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -54.62 -42.2 70.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.201 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -110.76 -10.88 14.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -173.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -77.07 145.2 73.08 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.216 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 36.9 Cg_exo -59.82 149.92 80.55 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.704 1.602 . . . . 0.0 111.174 173.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -54.8 -34.32 84.5 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.681 1.588 . . . . 0.0 111.2 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 94.8 p -74.4 -17.03 60.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.177 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -99.93 -0.97 38.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.267 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -60.39 -41.42 93.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.219 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.26 -32.44 71.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -71.25 -35.62 71.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.212 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 46.7 mm -75.1 -45.0 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -59.22 -38.33 79.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -55.64 -49.07 73.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.196 176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.99 -35.09 79.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.254 -176.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -79.92 -22.31 42.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.235 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 86.89 26.36 32.0 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 94.6 t -87.04 124.89 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.769 0.319 . . . . 0.0 111.254 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.4 p -97.17 -25.73 15.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.195 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -99.08 78.19 2.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.184 175.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 59.3 tp -62.21 -44.91 95.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.264 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.13 -37.19 86.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 -176.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -59.74 -40.74 97.0 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.8 mmt -72.38 -33.84 67.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.351 . . . . 0.0 111.214 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 84.9 mt -70.11 -29.73 66.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.199 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.34 -34.94 48.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -87.15 -6.06 58.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.505 ' C ' HD23 ' A' ' 348' ' ' LEU . 5.8 tt -51.76 -57.57 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.2 176.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.499 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 179.925 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.813 0.34 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.2 160.12 30.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.189 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 79.1 t -61.83 -42.19 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.262 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -75.86 -22.37 56.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.23 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.25 -33.19 69.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 170.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.6 mt -70.24 -44.19 77.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.234 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 96.8 mt -60.62 -30.79 70.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.188 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -51.74 -40.47 60.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.209 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -108.3 -10.04 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.195 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -74.79 152.67 87.02 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.249 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 41.5 Cg_exo -57.84 132.27 48.83 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.753 1.635 . . . . 0.0 111.185 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 75.4 Cg_exo -54.6 -35.22 85.81 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.69 1.593 . . . . 0.0 111.208 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.1 p -75.12 -17.24 60.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -106.93 17.04 23.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.182 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -64.91 -32.6 74.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.218 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.92 -43.55 68.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.214 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.51 -40.51 93.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.146 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.88 -44.96 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.229 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.07 -57.14 12.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -70.31 -24.1 62.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.163 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -61.76 -30.18 70.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.179 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -104.83 9.92 34.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.279 -177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.4 18.88 67.73 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 85.8 t -96.1 125.08 49.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 111.173 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 58.6 p -102.01 -24.84 13.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.218 176.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -93.53 84.08 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.198 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 50.6 tp -64.93 -46.07 83.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.206 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.73 -34.77 76.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.167 -176.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -60.27 -38.25 94.28 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.7 mmt -74.47 -32.64 62.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.837 0.351 . . . . 0.0 111.192 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 94.4 mt -73.01 -24.95 60.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.205 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.99 -35.0 74.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.31 -32.16 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.223 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 348' ' ' LEU . 4.3 tt -57.39 -55.49 34.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.489 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -178.988 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.829 0.347 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -75.08 -16.97 60.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.08 -56.13 19.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.19 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 -75.61 -19.53 59.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.157 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.24 -36.9 77.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.227 172.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.11 -42.68 79.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 171.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.45 -35.13 75.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.253 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -56.22 -40.2 73.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.261 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -98.1 4.39 49.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -100.65 156.73 34.85 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.69 152.52 64.54 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.7 1.6 . . . . 0.0 111.203 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -70.34 -18.09 34.5 Favored 'Trans proline' 0 C--N 1.327 -0.566 0 C-N-CA 121.67 1.58 . . . . 0.0 111.172 -172.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.9 p -77.63 -16.87 58.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.191 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -112.47 9.79 19.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.195 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -66.49 -35.69 80.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.277 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -72.16 -39.11 68.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.224 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.16 -39.05 89.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.171 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 93.0 mt -70.01 -49.92 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -56.11 -48.71 75.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.169 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -66.81 -28.7 68.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.218 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -65.04 -30.03 70.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -93.45 -9.37 38.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 88.7 17.94 55.66 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 88.0 t -93.75 124.83 46.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 111.183 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 82.4 p -100.43 -26.59 13.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.243 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -85.18 75.0 10.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.199 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.2 -43.37 95.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.222 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.63 -37.09 80.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -61.89 -38.76 96.54 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -72.11 -30.69 65.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.825 0.345 . . . . 0.0 111.243 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.05 -26.13 59.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.154 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.81 -35.06 77.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.137 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.13 -32.37 50.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 173.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.676 ' C ' HD23 ' A' ' 348' ' ' LEU . 4.2 tt -54.95 -53.05 60.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.247 175.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.201 -1.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.203 -179.408 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.849 0.357 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -129.96 11.69 5.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.236 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 8.3 p -65.23 -20.39 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.212 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -65.28 -20.07 66.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.12 -33.48 73.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.238 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.2 mt -72.14 -39.53 65.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.261 170.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.4 -20.95 65.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.191 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -52.37 -44.27 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.243 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -108.39 15.54 23.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.196 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -100.51 147.75 34.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.151 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 37.2 Cg_exo -60.77 145.6 98.7 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.705 1.604 . . . . 0.0 111.233 173.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 76.7 Cg_exo -53.95 -34.11 75.28 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.686 1.591 . . . . 0.0 111.216 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 92.0 p -71.64 -19.48 62.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.219 -175.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -100.02 -0.56 38.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.202 -174.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -58.77 -50.78 72.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.99 -42.62 89.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.176 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.39 -38.03 84.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 86.9 mt -68.4 -46.47 80.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.202 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -54.86 -45.63 74.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.186 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -65.31 -30.04 70.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -70.3 -21.87 62.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -104.79 8.58 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.279 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.01 24.83 70.67 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 93.9 t -102.01 121.2 52.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.761 0.315 . . . . 0.0 111.241 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.5 p -102.9 -26.51 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.206 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -85.03 74.8 10.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.26 177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 60.3 tp -65.73 -40.0 91.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.282 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -64.91 -35.76 82.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.217 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -65.14 -36.95 93.54 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.1 mmt -72.69 -38.09 67.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 111.151 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.86 -20.25 59.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -72.27 -42.3 65.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -65.21 -33.78 76.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.201 174.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.05 -48.49 68.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.177 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.2 -1.505 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 178.86 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.803 0.335 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -76.61 160.0 29.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.207 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 78.9 t -63.75 -43.49 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.242 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -73.89 -21.59 60.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.211 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -72.11 -37.16 69.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 171.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.9 mt -65.05 -42.55 94.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 170.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.03 -34.19 77.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.236 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 80.7 ttt180 -57.27 -40.98 78.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -98.88 20.83 12.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.19 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -119.7 156.93 53.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.249 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.57 149.55 61.87 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.65 1.567 . . . . 0.0 111.14 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.47 -15.39 27.8 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.663 1.575 . . . . 0.0 111.266 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.0 p -78.69 -15.29 58.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.215 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.75 25.01 8.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.221 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -72.36 -36.15 68.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.198 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.57 -39.5 73.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.162 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.04 -38.0 89.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 91.3 mt -69.54 -51.78 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.199 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.47 -42.94 75.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -65.86 -29.88 70.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.252 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -75.57 -13.43 60.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.252 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -105.01 1.41 28.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.197 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.83 24.94 68.31 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 92.3 t -100.14 116.72 44.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.778 0.323 . . . . 0.0 111.154 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.8 p -95.9 -27.56 15.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.208 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -84.96 74.82 10.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.22 176.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 55.0 tp -64.27 -42.28 96.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.165 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.89 -36.32 80.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.253 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -60.54 -39.91 97.08 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.3 mmt -71.54 -32.42 68.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.204 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.09 -24.9 58.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.02 -35.01 74.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 172.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.08 -33.39 61.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.205 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 348' ' ' LEU . 4.7 tt -56.92 -55.15 38.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.179 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.201 -1.5 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 -178.902 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.848 0.356 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -95.92 -19.76 19.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.256 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 321' ' ' LEU . 2.5 p -61.9 -46.0 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 -172.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -78.54 -18.28 54.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.273 -174.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.97 -35.25 62.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.262 171.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 97.4 mt -76.79 -36.55 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.191 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 317' ' ' VAL . 62.4 mt -55.33 -32.64 62.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.173 178.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.22 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -104.98 1.13 28.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.192 -176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -97.57 143.43 26.17 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.12 -176.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.434 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 31.8 Cg_exo -59.3 151.68 65.99 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.729 1.62 . . . . 0.0 111.203 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 75.7 Cg_exo -55.09 -35.16 89.82 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.757 1.638 . . . . 0.0 111.161 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 91.4 p -74.35 -18.23 60.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.244 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -100.05 1.12 42.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.248 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 -53.54 -51.54 62.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.7 -42.03 99.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.247 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.05 -38.71 89.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 -175.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 33.6 mm -63.75 -41.96 94.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.261 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -63.26 -38.35 90.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.193 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -64.22 -32.78 74.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.207 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -65.1 -26.74 68.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -102.64 -1.18 30.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.168 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 75.01 24.98 70.24 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 84.4 t -96.25 125.16 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 111.17 -177.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.4 p -96.73 -25.46 15.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -84.96 74.86 10.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 63.8 tp -64.09 -44.29 92.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.262 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.2 -38.92 88.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 -176.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -62.74 -36.96 94.05 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.9 mmt -74.92 -28.94 60.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.83 0.348 . . . . 0.0 111.239 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 93.3 mt -74.89 -24.05 58.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -69.97 -30.33 67.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.244 171.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.59 -31.79 41.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 172.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.657 ' C ' HD23 ' A' ' 348' ' ' LEU . 3.9 tt -53.85 -59.24 4.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.165 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.201 -1.495 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.295 -178.269 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -109.95 22.6 15.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.207 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.1 -20.47 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.186 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . 0.422 ' HA ' ' HB2' ' A' ' 321' ' ' LEU . 65.1 p-90 -62.47 -22.71 66.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.54 -34.46 77.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.193 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.96 -41.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.192 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 318' ' ' TRP . 3.8 mp -63.39 -26.92 68.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.228 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -54.18 -40.26 67.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.248 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -110.74 19.66 18.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.186 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 325' ' ' PRO . . . -110.97 149.65 40.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.258 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 324' ' ' ALA . 32.2 Cg_exo -57.99 154.56 38.26 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.765 1.643 . . . . 0.0 111.175 174.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.24 -21.7 47.68 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.743 1.629 . . . . 0.0 111.205 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 97.3 p -77.36 -16.31 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.259 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -99.85 -3.04 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.191 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -59.28 -50.47 73.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.216 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.82 -48.62 68.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.188 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -60.3 -54.35 46.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.23 -176.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 97.4 mt -56.98 -45.98 83.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.168 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.59 -45.31 77.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -65.32 -30.74 71.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.193 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -69.14 -22.32 63.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.245 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -104.79 5.54 33.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 77.89 24.12 65.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.2 t -98.88 122.71 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 81.8 p -104.5 -25.0 12.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.235 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -84.9 73.84 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.28 -39.41 89.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.168 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.54 -36.09 83.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.175 -178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -64.87 -41.1 97.62 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 36.8 mmt -66.78 -40.46 88.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 111.181 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.8 -26.27 59.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.75 -43.25 84.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 172.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -77.49 -20.73 53.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.524 ' C ' HD23 ' A' ' 348' ' ' LEU . 5.6 tt -64.94 -56.19 14.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 173.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.201 -1.484 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.183 -178.266 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.886 0.374 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -85.03 75.51 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.239 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 74.9 t -71.28 -30.29 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.201 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -55.03 -28.91 55.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.58 -35.13 78.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.219 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.12 -36.32 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.199 172.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 329' ' ' TYR . 68.7 mt -69.96 -20.1 63.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -52.16 -40.94 62.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -110.2 20.13 18.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.246 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -114.24 146.37 35.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.66 153.26 43.66 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.712 1.608 . . . . 0.0 111.172 174.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.16 -21.05 49.16 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.66 1.574 . . . . 0.0 111.201 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 95.4 p -76.97 -15.72 59.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -99.98 -1.84 36.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.223 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . 0.404 ' HA ' HD22 ' A' ' 321' ' ' LEU . 12.0 m-30 -60.37 -49.61 76.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.03 -48.02 75.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.235 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -60.81 -52.53 64.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 91.0 mt -57.16 -49.01 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -55.71 -46.83 77.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.191 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -63.01 -34.75 78.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.248 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.4 -24.61 66.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -98.63 3.01 47.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.145 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 81.17 22.03 61.66 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 97.9 t -104.95 113.18 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.739 0.304 . . . . 0.0 111.184 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 78.0 p -95.74 -20.01 19.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -84.89 74.77 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.171 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.15 -39.82 90.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.159 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.37 -34.95 74.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.157 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -61.37 -43.62 99.12 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 171.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 38.3 mmt -67.45 -30.88 70.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 111.197 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.06 -31.84 61.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.231 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.9 -33.25 71.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.188 173.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -79.78 -28.0 40.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.178 174.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 55.4 tp -66.32 -48.62 69.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.224 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.199 -1.559 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.653 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.803 0.335 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -80.05 170.0 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 12.3 p -69.58 -37.23 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.203 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' TRP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 321' ' ' LEU . 69.2 p-90 -84.44 -22.2 30.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.248 177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.27 -41.91 84.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.258 174.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.49 -40.07 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 321' ' ' LEU . 0.4 OUTLIER -53.71 -29.96 41.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.202 178.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -53.97 -45.27 71.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.196 176.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -102.5 -15.48 16.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.177 -173.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -82.07 152.09 67.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.232 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 326' ' ' PRO . 87.5 Cg_endo -73.4 147.29 41.23 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.696 1.597 . . . . 0.0 111.175 175.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 325' ' ' PRO . 76.9 Cg_exo -54.48 -31.28 68.22 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.735 1.623 . . . . 0.0 111.203 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 96.0 p -68.38 -19.86 64.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.208 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -116.92 23.57 11.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.174 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -70.16 -29.93 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.208 174.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -72.25 -35.16 68.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -71.89 -34.34 69.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.228 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 45.6 mm -76.35 -45.47 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.2 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.01 77.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -53.85 -44.54 70.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -68.96 -27.59 65.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -95.19 -7.9 37.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.218 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 78.63 26.12 59.48 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.86 129.07 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 111.197 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' THR . . . . . . . . . . . . . 71.3 p -115.18 5.08 14.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.182 -176.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -130.33 91.93 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.204 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 83.2 mt -74.72 -23.76 58.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.23 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.16 -37.05 75.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.182 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . -66.89 -35.31 89.37 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' MET . . . . . . . . . . . . . 37.7 mmt -74.67 -29.91 61.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.824 0.345 . . . . 0.0 111.219 175.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.88 -35.69 80.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.23 -34.04 74.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 172.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -75.07 -29.77 60.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.245 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 98.1 mt -74.36 -29.75 61.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.199 -1.56 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.18 179.331 . . . . . . . . 0 0 . 1 stop_ save_